

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Tumour necrosis factor signalling in health and... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/8-111/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/8-111" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Tumour necrosis factor signalling in health and disease" />
    
            <meta name="og:title" content="F1000Research Article: Tumour necrosis factor signalling in health and disease.">
            <meta name="og:description" content="Read the latest article version by Jonathan Holbrook, Samuel Lara-Reyna, Heledd Jarosz-Griffiths, Michael F. McDermott, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="18612">
            <meta name="article-id" content="17023">
            <meta name="dc.title" content="Tumour necrosis factor signalling in health and disease">
            <meta name="dc.description" content="The master pro-inflammatory cytokine, tumour necrosis factor (TNF), has been shown to modulate multiple signalling pathways, with wide-ranging downstream effects. TNF plays a vital role in the typical immune response through the regulation of a number of pathways encompassing an immediate inflammatory reaction with significant innate immune involvement as well as cellular activation with subsequent proliferation and programmed cell death or necrosis. As might be expected with such a broad spectrum of cellular effects and complex signalling pathways, TNF has also been implicated in a number of disease states, such as rheumatoid arthritis, ankylosing spondylitis, and Crohn&rsquo;s disease. Since the time of its discovery over 40 years ago, TNF ligand and its receptors, TNF receptor (TNFR) 1 and 2, have been categorised into two complementary superfamilies, namely TNF (TNFSF) and TNFR (TNFRSF), and 19 ligands and 29 receptors have been identified to date. There have been significant advances in our understanding of TNF signalling pathways in the last decade, and this short review aims to elucidate some of the most recent advances involving TNF signalling in health and disease.">
            <meta name="dc.subject" content="TNF, TNFR, Cell death, Immunometabolism, Autoinflammatory">
            <meta name="dc.creator" content="Holbrook, Jonathan">
            <meta name="dc.creator" content="Lara-Reyna, Samuel">
            <meta name="dc.creator" content="Jarosz-Griffiths, Heledd">
            <meta name="dc.creator" content="McDermott, Michael F.">
            <meta name="dc.date" content="2019/01/28">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.17023.1">
            <meta name="dc.source" content="F1000Research 2019 8:111">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="TNF">
            <meta name="prism.keyword" content="TNFR">
            <meta name="prism.keyword" content="Cell death">
            <meta name="prism.keyword" content="Immunometabolism">
            <meta name="prism.keyword" content="Autoinflammatory">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2019/01/28">
            <meta name="prism.volume" content="8">
            <meta name="prism.number" content="111">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.17023.1">
            <meta name="prism.url" content="https://f1000research.com/articles/8-111">
            <meta name="citation_title" content="Tumour necrosis factor signalling in health and disease">
            <meta name="citation_abstract" content="The master pro-inflammatory cytokine, tumour necrosis factor (TNF), has been shown to modulate multiple signalling pathways, with wide-ranging downstream effects. TNF plays a vital role in the typical immune response through the regulation of a number of pathways encompassing an immediate inflammatory reaction with significant innate immune involvement as well as cellular activation with subsequent proliferation and programmed cell death or necrosis. As might be expected with such a broad spectrum of cellular effects and complex signalling pathways, TNF has also been implicated in a number of disease states, such as rheumatoid arthritis, ankylosing spondylitis, and Crohn&rsquo;s disease. Since the time of its discovery over 40 years ago, TNF ligand and its receptors, TNF receptor (TNFR) 1 and 2, have been categorised into two complementary superfamilies, namely TNF (TNFSF) and TNFR (TNFRSF), and 19 ligands and 29 receptors have been identified to date. There have been significant advances in our understanding of TNF signalling pathways in the last decade, and this short review aims to elucidate some of the most recent advances involving TNF signalling in health and disease.">
            <meta name="citation_description" content="The master pro-inflammatory cytokine, tumour necrosis factor (TNF), has been shown to modulate multiple signalling pathways, with wide-ranging downstream effects. TNF plays a vital role in the typical immune response through the regulation of a number of pathways encompassing an immediate inflammatory reaction with significant innate immune involvement as well as cellular activation with subsequent proliferation and programmed cell death or necrosis. As might be expected with such a broad spectrum of cellular effects and complex signalling pathways, TNF has also been implicated in a number of disease states, such as rheumatoid arthritis, ankylosing spondylitis, and Crohn&rsquo;s disease. Since the time of its discovery over 40 years ago, TNF ligand and its receptors, TNF receptor (TNFR) 1 and 2, have been categorised into two complementary superfamilies, namely TNF (TNFSF) and TNFR (TNFRSF), and 19 ligands and 29 receptors have been identified to date. There have been significant advances in our understanding of TNF signalling pathways in the last decade, and this short review aims to elucidate some of the most recent advances involving TNF signalling in health and disease.">
            <meta name="citation_keywords" content="TNF, TNFR, Cell death, Immunometabolism, Autoinflammatory">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Jonathan Holbrook">
            <meta name="citation_author_institution" content="Leeds Institute of Rheumatic and Musculoskeletal Medicine (LIRMM), Leeds, UK">
            <meta name="citation_author_institution" content="Leeds Institute of Medical Research at St. James&rsquo;s, Leeds, UK">
            <meta name="citation_author_institution" content="Leeds Cystic Fibrosis Trust Strategic Research Centre, Leeds, UK">
            <meta name="citation_author" content="Samuel Lara-Reyna">
            <meta name="citation_author_institution" content="Leeds Institute of Rheumatic and Musculoskeletal Medicine (LIRMM), Leeds, UK">
            <meta name="citation_author_institution" content="Leeds Institute of Medical Research at St. James&rsquo;s, Leeds, UK">
            <meta name="citation_author_institution" content="Leeds Cystic Fibrosis Trust Strategic Research Centre, Leeds, UK">
            <meta name="citation_author" content="Heledd Jarosz-Griffiths">
            <meta name="citation_author_institution" content="Leeds Institute of Rheumatic and Musculoskeletal Medicine (LIRMM), Leeds, UK">
            <meta name="citation_author_institution" content="Leeds Institute of Medical Research at St. James&rsquo;s, Leeds, UK">
            <meta name="citation_author_institution" content="Leeds Cystic Fibrosis Trust Strategic Research Centre, Leeds, UK">
            <meta name="citation_author" content="Michael F. McDermott">
            <meta name="citation_author_institution" content="Leeds Institute of Rheumatic and Musculoskeletal Medicine (LIRMM), Leeds, UK">
            <meta name="citation_author_institution" content="Leeds Cystic Fibrosis Trust Strategic Research Centre, Leeds, UK">
            <meta name="citation_publication_date" content="2019/01/28">
            <meta name="citation_volume" content="8">
            <meta name="citation_publication_number" content="111">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.17023.1">
            <meta name="citation_firstpage" content="111">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/8-111/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/8-111.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=18612 /> <input type=hidden id=articleId name=articleId value=17023 /> <input type=hidden id=xmlUrl value="/articles/8-111/v1/xml"/> <input type=hidden id=xmlFileName value="-8-111-v1.xml"> <input type=hidden id=article_uuid value=6c81e12c-4ea8-4319-b9f3-695207949622 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Tumour necrosis factor signalling in health and disease"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.17023.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.17023.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/8-111"
  },
  "headline": "Tumour necrosis factor signalling in health and disease",
  "datePublished": "2019-01-28T10:23:12",
  "dateModified": "2019-01-28T10:23:12",
  "author": [
    {
      "@type": "Person",
      "name": "Jonathan Holbrook"
    },    {
      "@type": "Person",
      "name": "Samuel Lara-Reyna"
    },    {
      "@type": "Person",
      "name": "Heledd Jarosz-Griffiths"
    },    {
      "@type": "Person",
      "name": "Michael F. McDermott"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "The master pro-inflammatory cytokine, tumour necrosis factor (TNF), has been shown to modulate multiple signalling pathways, with wide-ranging downstream effects. TNF plays a vital role in the typical immune response through the regulation of a number of pathways encompassing an immediate inflammatory reaction with significant innate immune involvement as well as cellular activation with subsequent proliferation and programmed cell death or necrosis. As might be expected with such a broad spectrum of cellular effects and complex signalling pathways, TNF has also been implicated in a number of disease states, such as rheumatoid arthritis, ankylosing spondylitis, and Crohn&rsquo;s disease. Since the time of its discovery over 40 years ago, TNF ligand and its receptors, TNF receptor (TNFR) 1 and 2, have been categorised into two complementary superfamilies, namely TNF (TNFSF) and TNFR (TNFRSF), and 19 ligands and 29 receptors have been identified to date. There have been significant advances in our understanding of TNF signalling pathways in the last decade, and this short review aims to elucidate some of the most recent advances involving TNF signalling in health and disease."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/8-111/v1",
            "name": "Tumour necrosis factor signalling in health and disease"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Tumour necrosis factor signalling in health and disease </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=18612 data-id=17023 data-downloads="" data-views="" data-scholar="10.12688/f1000research.17023.1" data-recommended="" data-doi="10.12688/f1000research.17023.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/8-111/v1/pdf?article_uuid=6c81e12c-4ea8-4319-b9f3-695207949622" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-17023-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-17023-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-17023-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Holbrook J, Lara-Reyna S, Jarosz-Griffiths H and McDermott MF. Tumour necrosis factor signalling in health and disease [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):111 (<a class=new-orange href="https://doi.org/10.12688/f1000research.17023.1" target=_blank>https://doi.org/10.12688/f1000research.17023.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-17023-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=17023 id=track-article-signin-17023 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/17023?target=/articles/8-111/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=18612 /> <input name=articleId type=hidden value=17023 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Tumour necrosis factor signalling in health and disease</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Jonathan Holbrook<sup>1-3</sup>,&nbsp;</span><span class="">Samuel Lara-Reyna<sup>1-3</sup>,&nbsp;</span><span class=""><a href="mailto:H.H.Griffiths@leeds.ac.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Heledd Jarosz-Griffiths</span></a><a href="https://orcid.org/0000-0001-5154-4815" target=_blank id=author-orcid-2><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-2><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-5154-4815</div><sup>1-3</sup>,&nbsp;</span><span class=""><a href="mailto:M.McDermott@leeds.ac.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Michael F. McDermott</span></a><a href="https://orcid.org/0000-0002-1015-0745" target=_blank id=author-orcid-3><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-3><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-1015-0745</div><sup>1,3</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Jonathan Holbrook<sup>1-3</sup>,&nbsp;</span><span class="">Samuel Lara-Reyna<sup>1-3</sup>,&nbsp;</span><span class=""><a href="mailto:H.H.Griffiths@leeds.ac.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Heledd Jarosz-Griffiths</span></a><a href="http://orcid.org/0000-0001-5154-4815" target=_blank id=mauthor-orcid-2><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-2><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-5154-4815</div><sup>1-3</sup>,&nbsp;</span><span class=""><a href="mailto:M.McDermott@leeds.ac.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Michael F. McDermott</span></a><a href="http://orcid.org/0000-0002-1015-0745" target=_blank id=mauthor-orcid-3><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-3><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-1015-0745</div><sup>1,3</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 28 Jan 2019 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.17023.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Leeds Institute of Rheumatic and Musculoskeletal Medicine (LIRMM), Leeds, UK<br/> <sup>2</sup> Leeds Institute of Medical Research at St. James&rsquo;s, Leeds, UK<br/> <sup>3</sup> Leeds Cystic Fibrosis Trust Strategic Research Centre, Leeds, UK<br/> <p> <div class=margin-bottom> Jonathan Holbrook <br/> <span>Roles: </span> Conceptualization, Project Administration, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Samuel Lara-Reyna <br/> <span>Roles: </span> Conceptualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Heledd Jarosz-Griffiths <br/> <span>Roles: </span> Conceptualization, Project Administration, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Michael F. McDermott <br/> <span>Roles: </span> Conceptualization, Project Administration, Supervision, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=44903-43377></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=44902-43376></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> The master pro-inflammatory cytokine, tumour necrosis factor (TNF), has been shown to modulate multiple signalling pathways, with wide-ranging downstream effects. TNF plays a vital role in the typical immune response through the regulation of a number of pathways encompassing an immediate inflammatory reaction with significant innate immune involvement as well as cellular activation with subsequent proliferation and programmed cell death or necrosis. As might be expected with such a broad spectrum of cellular effects and complex signalling pathways, TNF has also been implicated in a number of disease states, such as rheumatoid arthritis, ankylosing spondylitis, and Crohn’s disease. Since the time of its discovery over 40 years ago, TNF ligand and its receptors, TNF receptor (TNFR) 1 and 2, have been categorised into two complementary superfamilies, namely TNF (TNFSF) and TNFR (TNFRSF), and 19 ligands and 29 receptors have been identified to date. There have been significant advances in our understanding of TNF signalling pathways in the last decade, and this short review aims to elucidate some of the most recent advances involving TNF signalling in health and disease. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> TNF, TNFR, Cell death, Immunometabolism, Autoinflammatory </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Heledd Jarosz-Griffiths (<a href="mailto:H.H.Griffiths@leeds.ac.uk">H.H.Griffiths@leeds.ac.uk</a>) <br> Michael F. McDermott (<a href="mailto:M.McDermott@leeds.ac.uk">M.McDermott@leeds.ac.uk</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding authors:</b> Heledd Jarosz-Griffiths, Michael F. McDermott </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The authors are supported by a grant (SRC009) from the Cystic Fibrosis Trust. JH is partially supported by the Leeds Institute of Medical Research. SL-R is supported by CONACyT. <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2019 Holbrook J <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Holbrook J, Lara-Reyna S, Jarosz-Griffiths H and McDermott MF. Tumour necrosis factor signalling in health and disease [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):111 (<a href="https://doi.org/10.12688/f1000research.17023.1" target=_blank>https://doi.org/10.12688/f1000research.17023.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 28 Jan 2019, <b>8</b>(F1000 Faculty Rev):111 (<a href="https://doi.org/10.12688/f1000research.17023.1" target=_blank>https://doi.org/10.12688/f1000research.17023.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 28 Jan 2019, <b>8</b>(F1000 Faculty Rev):111 (<a href="https://doi.org/10.12688/f1000research.17023.1" target=_blank>https://doi.org/10.12688/f1000research.17023.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d11054e231>Introduction</h2><p class="" id=d11054e234>Since the identification of tumour necrosis factor (TNF) in 1975<sup><a href="#ref-1">1</a></sup> and its isolation and characterisation in 1984<sup><a href="#ref-2">2</a></sup>, the 17 kDa secreted form of this molecule has been established as a potent inflammatory cytokine with a myriad of diverse functions across a number of different cell types. Initially discovered as a serum factor which induced cell death in tumour cells<sup><a href="#ref-1">1</a></sup> and thought at that time to be a promising target as a cancer treatment, TNF was later realised to be a potential target for the treatment of inflammatory diseases, such as rheumatoid arthritis (RA)<sup><a href="#ref-3">3</a></sup>, Crohn’s disease (CD)<sup><a href="#ref-4">4</a></sup>, ankylosing spondylitis (AS)<sup><a href="#ref-5">5</a></sup>, and psoriasis<sup><a href="#ref-6">6</a></sup>. However, localised administration of TNF is used as an effective therapy via isolated limb perfusion in patients with melanoma with multiple in-transit metastases<sup><a href="#ref-7">7</a></sup>.</p><p class="" id=d11054e270>TNF is produced primarily by monocytes/macrophages, but a number of other cell types, such as T and B lymphocytes, mast cells, natural killer cells, neutrophils, fibroblasts, and osteoclasts, can also secrete TNF<sup><a href="#ref-8">8</a></sup>, albeit in smaller quantities.</p><p class="" id=d11054e277>TNF is first produced as a 26 kDa 233-amino-acid transmembrane protein (mTNF) that is expressed on the cell surface, where it either continues to reside or is actively cleaved by TNF-converting enzyme to produce a 17 kDa 157-amino-acid soluble TNF (sTNF) form; sTNF is subsequently released and becomes detectable in the blood plasma<sup><a href="#ref-9">9</a></sup>. mTNF and sTNF both perform cellular functions mediated by either of its two receptors: TNFR1, expressed across all human tissues, and TNFR2, expressed primarily in immune cells, neurons, and endothelial cells<sup><a href="#ref-10">10</a>,<a href="#ref-11">11</a></sup>. mTNF functions as a ligand transmitting cell-to-cell interactions and, when bound to TNFR2 (its primary biological target)<sup><a href="#ref-12">12</a></sup>, is able to induce a more potent response than sTNF; interestingly, mTNF has also been shown to function as a receptor by initiating a cell signalling cascade through outside-to-inside signalling<sup><a href="#ref-13">13</a></sup>. TNFR1 and 2, though similar in their extracellular structures at the mTNF- and sTNF-binding sites, have distinct intracellular structures which bind to a number of adaptor proteins<sup><a href="#ref-14">14</a></sup>. TNFR1’s cytoplasmic tail contains a death domain (DD), thereby allowing it to recruit the TNFR1-associated DD (TRADD)<sup><a href="#ref-15">15</a></sup>; TNFR2, on the other hand, does not have an intracellular DD and recruits the TNFR-associated factor (TRAF) 1 and 2 proteins instead (<a href="#f1">Figure 1</a>)<sup><a href="#ref-16">16</a></sup>. Whereas both TNFR1 and 2 signalling pathways may lead to the activation of nuclear factor-kappa B (NF-κB) and the induction of a cell survival response, TNFR1 is also capable of inducing a cell death response depending on prevailing physiological circumstances; however, the regulation of the two TNFRs is dependent on the cellular environment and is not fully understood (<a href="#f1">Figure 1</a>)<sup><a href="#ref-17">17</a></sup>. The past decade has seen remarkable progress in the elucidation of regulatory cross-talk between TNFR1 and 2 as well as the individual but complementary functions of these two pleiotropic receptors<sup><a href="#ref-18">18</a>,<a href="#ref-19">19</a></sup>.</p><a name=f1 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/18612/fb36a784-6067-4c40-bd51-669711da057a_figure1.gif"><img alt="fb36a784-6067-4c40-bd51-669711da057a_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/18612/fb36a784-6067-4c40-bd51-669711da057a_figure1.gif"></a><div class=caption><h3>Figure 1. Overview of tumour necrosis factor (TNF): TNF receptor 1/2 (TNFR1/2) signalling pathways.</h3><p id=d11054e339>Both soluble TNF (sTNF) and membrane TNF (mTNF) activate TNFR1. TNFR1 contains a death domain which interacts with TNFR1-associated death domain (TRADD). Depending on the ubiquitination state of receptor-interacting serine/threonine-protein kinase 1 (RIPK1), the cell undergoes apoptosis (via complexes IIa and IIb), necrosis (via complex IIc), or cell survival (via complex I). The formation of complexes IIa and IIb leads to the cleavage of pro-caspase-8 to form caspase-8 and induction of apoptosis. When complex IIc forms, the mixed lineage kinase domain-like protein (MLKL) is activated, inducing necroptosis. Upon the formation of complex I, cell survival is induced via the activation of nuclear factor-kappa B (NF-κB) and AP1 transcription factors because of RIPK1 ubiquitination. TNFR2, however, is activated primarily by mTNF and does not contain an intracellular death domain but interacts directly with TNFR-associated factor (TRAF) 1 and 2 to induce the formation of complex I with induction of homeostatic signals.</p></div></div><p class="" id=d11054e347>Upon binding of TNF to TNFR1, TNFR1 undergoes a conformational change in its DD, whereby both TRADD and receptor-interacting serine/threonine protein kinase 1 (RIPK1) are recruited, leading to the formation of complex I and the initiation of cell survival via activation of the NF-κB pathway (<a href="#f2">Figure 2</a>)<sup><a href="#ref-20">20</a>–<a href="#ref-22">22</a></sup>. TNF-mediated cell death is highly dependent on various cell death check points, which regulate the pro-survival pathway; when these check points are disrupted, TNF-mediated signalling occurs through the formation of complexes IIa, IIb, and IIc<sup><a href="#ref-23">23</a></sup>. The ubiquitination status of RIPK1 is a critical determinant of whether a particular signalling pathway promotes cell survival, through complex I<sup><a href="#ref-24">24</a></sup>, apoptosis (controlled cell death), via complex IIb<sup><a href="#ref-25">25</a>,<a href="#ref-26">26</a></sup>, or necrosis (uncontrolled cell death), through complex IIc<sup><a href="#ref-27">27</a>,<a href="#ref-28">28</a></sup>.</p><a name=f2 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/18612/fb36a784-6067-4c40-bd51-669711da057a_figure2.gif"><img alt="fb36a784-6067-4c40-bd51-669711da057a_figure2.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/18612/fb36a784-6067-4c40-bd51-669711da057a_figure2.gif"></a><div class=caption><h3>Figure 2. Overview of the tumour necrosis factor receptor 1 (TNFR1) signalling pathway.</h3><p id=d11054e393>In the binding of TNF to TNFR1, TNFR1 recruits the TNFR1-associated death domain (TRADD), which then binds to receptor-interacting serine/threonine-protein kinase 1 (RIPK1), TNFR-associated factor 2 or 5 (TRAF2/5), and cellular inhibitor of apoptosis protein 1 or 2 (cIAP1/2) to form complex I. cIAP1/2 and the linear ubiquitin chain assembly complex (LUBAC), consisting of HOIP, HOIL, and SHARPIN, add Met1-linked and Lys63-linked polyubiquitin chains, respectively, to RIPK1. This stabilises RIPK1, amplifying its signal. Lys63-linked chains on RIPK1 recruit the transforming growth factor-beta (TGFβ)-activated kinase 1 (TAK1) complex, consisting of TGFβ-activated kinase 1 and mitogen-activated protein kinase (MAPK)-binding protein 2 and 3 (TAB2 and 3) and TAK1. The TAK1 complex phosphorylates MAPK, Jun N-terminal kinase (JNK), and the IκB kinase (IKK) complex. This results in the translocation of transcription factors AP1 and nuclear factor-kappa B (NF-κB) into the nucleus, leading to the transcription of target genes. RIPK1 is deubiquitinated by cylindromatosis tumour suppressor protein deubiquitinase (CYLD), facilitating its dissociation from complex I to form complex IIb, consisting of RIPK1, RIPK3, FAS-associated death domain (FADD), caspase-8, and FLICE-like inhibitory protein long (cFLIP<sub>L</sub>). cFLIP<sub>L</sub> regulates both the apoptosis and the necrosis pathway, preventing caspase-8 activation to avert apoptosis. cFLIP<sub>L</sub> acts in complex with caspase-8 to cleave RIPK1 and RIPK3 to inhibit their aggregation and the activation of mixed lineage kinase domain-like protein (MLKL), which would result in necrosis. HOIL-1, heme-oxidised iron regulatory protein 2 ubiquitin ligase 1; HOIP, HOIL-1 interacting protein.</p></div></div><p class="" id=d11054e409>TNF signalling is tightly regulated by post-translational ubiquitination, an essential mechanism for the regulation of many biological processes. Ubiquitin (Ub) chains are assembled in response to activation of the TNF receptors and then attached to target substrates to modulate protein function. The type of Ub chains is determined by their specific linkage type, which are assembled to generate distinct intracellular signals. Deubiquitinase (DUB) enzymes reverse the process of ubiquitination by hydrolysing Ub moieties from the modified protein substrates<sup><a href="#ref-29">29</a></sup>. Ub retains seven lysine sites (K6, K11, K27, K29, K33, K48, and K63) at the N-terminal methionine (Met-1) and the C-terminal glycine site. The main sites of interest are K48 and K63, as they are essential for the activation of the NF-κB pathway<sup><a href="#ref-30">30</a></sup>.</p><p class="" id=d11054e420>The activation of complex I relies on the ubiquitination of RIPK1 and consists of TRADD<sup><a href="#ref-15">15</a></sup>, RIPK1<sup><a href="#ref-21">21</a></sup>, TRAF2 or 5<sup><a href="#ref-31">31</a></sup>, cellular inhibitor of apoptosis protein (cIAP) 1 or 2<sup><a href="#ref-32">32</a></sup>, and linear Ub chain assembly complex (LUBAC) (<a href="#f2">Figure 2</a>)<sup><a href="#ref-33">33</a></sup>. LUBAC is composed of three proteins: heme-oxidised iron regulatory protein (IRP) 2 Ub ligase 1 (HOIL-1), shank-associated RH domain-interacting protein (SHARPIN), and HOIL-1 interacting protein (HOIP). cIAP and LUBAC add K63-linked and Met1-linked polyUb chains, respectively, to RIPK1, stabilising the Ub structure and amplifying its signal<sup><a href="#ref-33">33</a>–<a href="#ref-35">35</a></sup>. This leads to the recruitment of transforming growth factor-beta (TGF-β)-activated kinase (TAK) 1 complex, consisting of TAK-binding protein (TAB) 2 and 3, and inhibitor of κB (IκB) kinase (IKK) complex, composed of the NF-κB essential modulator (IKKγ, also known as NEMO), IKKα, and IKKβ<sup><a href="#ref-24">24</a></sup>. The TAK1 complex phosphorylates mitogen-activated protein kinase (MAPK), leading to a signalling cascade whereby c-Jun N-terminal kinase (JNK), p38, and AP1 transcription factors are activated, and the IKKβ activates NF-κB. This ultimately leads to pro-survival signalling, where inflammation and the proliferation of immune cells are induced<sup><a href="#ref-24">24</a></sup>. Following the activation of NF-κB, cellular FLICE-like inhibitory protein long (cFLIP<sub>L</sub>) translocates to complex IIa in order to prevent caspase-8 activation. However, if the late NF-κB-dependent check point is disrupted and cFLIP<sub>L</sub> levels are consequently reduced, apoptosis is initiated via complex IIa (composed of TRADD, FAS-associated DD [FADD], and pro-caspase-8) through auto-activation of pro-caspase-8<sup><a href="#ref-36">36</a>–<a href="#ref-38">38</a></sup>. In contrast to the late check point, the early check point, which occurs immediately after ligand binding, is initiated by the ubiquitination of RIPK1 by cIAP and LUBAC (<a href="#f2">Figure 2</a>)<sup><a href="#ref-39">39</a>–<a href="#ref-41">41</a></sup>.</p><p class="" id=d11054e486>When RIPK1 is not ubiquitinated, complex IIb is formed; in order for this to occur, the cylindromatosis tumour suppressor protein DUB (CYLD) enzyme deubiquitinates RIPK1, thereby allowing it to disassociate from complex I<sup><a href="#ref-42">42</a></sup> and form complex IIb, whereby TRADD is replaced by RIPK3, upon degradation of cIAP1 and 2<sup><a href="#ref-25">25</a>,<a href="#ref-26">26</a>,<a href="#ref-43">43</a></sup>. This, in turn, leads to the cleavage of pro-caspase-8 to caspase-8, and activation of the caspase signalling cascade results in apoptosis (<a href="#f2">Figure 2</a>). To ensure that apoptosis, and not necrosis (unregulated cell death), is induced, which could lead to unwanted inflammation and damage to the surrounding tissues, caspase-8 or pro-caspase-8 in complex with cFLIP<sub>L</sub> is required to cleave RIPK1 and 3<sup><a href="#ref-25">25</a>,<a href="#ref-44">44</a></sup>. However, RIPK1 and 3 may, on occasions, remain uncleaved, leading to their aggregation and the formation of complex IIc, with the resultant activation of mixed lineage kinase domain-like protein (MLKL) and the induction of a regulated form of necrotic cell death, necroptosis (<a href="#f2">Figure 2</a>)<sup><a href="#ref-27">27</a>,<a href="#ref-28">28</a></sup>.</p><p class="" id=d11054e527>TNFR2 interacts directly with TRAF1 or 2 to recruit cIAP1 or 2 to promote cell survival signalling through the formation of complex I and the induction of NF-κB, MAPK, and Akt, promoting cell proliferation and tissue regeneration. The binding of TRAF2 to TNFR2 is considerably weaker than TRAF2’s binding to TRADD<sup><a href="#ref-45">45</a>,<a href="#ref-46">46</a></sup>, indicating a regulatory role of the TNFR1 signalling pathway<sup><a href="#ref-45">45</a>,<a href="#ref-47">47</a></sup>. It is hoped that, through greater understanding of TNF signalling in health and disease, improved therapies can be developed to inhibit this potent cytokine in a more target-specific manner.</p><p class="" id=d11054e545>Throughout the TNF signalling pathway, there are a number of proteins that are essential for negative regulation of the pathway. A20 contains both DUB and E3 ligase domains and plays a vital regulatory role at multiple steps of the TNF signalling pathway, such as its removal of K48- and K63-linked Ub chains from RIP1 through its zinc finger (ZF) 4 domain<sup><a href="#ref-48">48</a>,<a href="#ref-49">49</a></sup> and its inhibition of the interaction between LUBAC and IKKγ through binding to their linear Ub chains via A20’s ZF7 domain upon TNF stimulation<sup><a href="#ref-50">50</a>,<a href="#ref-51">51</a></sup>. A20, as well as the regulatory molecule TAX1BP1, has also been shown to inhibit the E3 ligase activities of TRAF2, TRAF6, and cIAP1 by interfering with E2 Ub enzymes Ubc13 and UbcH5c, disrupting NF-κB signalling<sup><a href="#ref-52">52</a></sup>. In 2015, it was documented, in a mouse embryonic fibroblast (MEF) model, that binding of A20 to linear Met1-linked polyUb chains protected the MEFs from CYLD-mediated degradation. This was shown to be dependent on A20’s ZF7 domain but was independent of its DUB activity and protected cells from TNF-induced RIPK1-dependent apoptosis (RDA)<sup><a href="#ref-53">53</a></sup>. Another DUB, ovarian tumour (OTU) DUB with linear linkage specificity (OTULIN), acts via its specific cleavage of Met1-linked polyUb chains after it binds to the HOIP component of the LUBAC<sup><a href="#ref-54">54</a></sup>. CYLD is another negative regulator of the TNF signalling pathway, removing Ub chains from several proteins such as TRAF2, TRAF6, IKKγ, and RIPK1 to regulate the NF-κB and JNK pathways<sup><a href="#ref-55">55</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d11054e582>Cell death</h2><p class="" id=d11054e585>The ubiquitination status of RIPK1 is a critical determinant of whether a cell undergoes RDA; a recent study describes a “detergent insoluble, highly ubiquitinated and activated RIPK1 pool”<sup><a href="#ref-56">56</a></sup>, termed iuRIPK1, which acts as an intermediate between complex I and cytosolic complex IIb formation and caspase activation. Using a systematic screen for RDA, the investigators found that iuRIPK1 is regulated by Parkinson’s disease-associated leucine-rich repeat kinase 2 (LRRK2), E3 Ub ligase, c-Cbl, and ALS-associated NEK1, suggesting a mechanistic link between RDA and neurodegenerative conditions<sup><a href="#ref-56">56</a></sup>. It is well documented that, in addition to its Ub status, kinase activity of RIPK1 is essential for RDA and necroptosis, both being induced by TNF<sup><a href="#ref-57">57</a>–<a href="#ref-59">59</a></sup>. In 2018, Meng <i>et al</i>. reported that C-terminal DD dimerisation of RIPK1, via K584, serves as an amplification mechanism to promote RIPK1 kinase activity and that increased expression, under pathological conditions, may promote its dimerisation and activation<sup><a href="#ref-60">60</a></sup>. In light of these discoveries, the question arises as to whether detergent-insoluble lipid rafts are providing a platform for the assembly of cell surface signalling complexes, under certain pathological conditions, and thus might act as a critical determinant in driving RIPK1-mediated cell death<sup><a href="#ref-61">61</a></sup>. Recent research has also found that RIPK1 prevents skin inflammation, via the inhibition of RIPK3-MLKL-dependent necroptosis, mediated by the cytoplasmic DNA sensor protein, Z-DNA-binding protein (ZBP1)<sup><a href="#ref-62">62</a>,<a href="#ref-63">63</a></sup>, and that deficiency of RIPK3, as well as an inactive form of RIPK3, reduces necroptosis and thereby the severity of inflammation in mouse models of tissue injury<sup><a href="#ref-64">64</a></sup>.</p><p class="" id=d11054e626>Controversy hangs over the role of A20 DUB, which has been shown in separate studies to either protect or promote TNF-mediated RDA<sup><a href="#ref-53">53</a>,<a href="#ref-65">65</a></sup>. A recently published report by Garcia-Carbonell <i>et al</i>.<sup><a href="#ref-65">65</a></sup> reported increased levels of <i>A20</i> gene expression in patients with irritable bowel disease (IBD), and intestinal epithelial cells have increased susceptibility to TNF-induced cell death. Similarly, stabilising the function of <i>A20</i>, in the form of homodimers, facilitated ripoptosome complex (consisting of RIP1 and cIAP1 and 2) assembly by binding linear Ub chains via ZF7, protecting RIPK1 from deubiquitination, resulting in enhanced caspase-8 recruitment and activation<sup><a href="#ref-65">65</a></sup>. A20 has also been shown to protect cells from necroptosis through the deubiquitination of RIPK3 in both T cells and fibroblasts<sup><a href="#ref-66">66</a></sup>.</p><p class="" id=d11054e658>Alongside their functional roles as E3 Ub ligases, the cIAPs are critical regulators of pro-inflammatory signalling pathways<sup><a href="#ref-67">67</a></sup>. The loss of IAP induces not only the formation of complex IIb and stimulates RDA but also caspase-8-dependent interleukin-1 beta (IL-1β) maturation and NLRP3 inflammasome signalling in macrophages, in a TLR4/TRIF-dependent manner which is independent of TNFR1<sup><a href="#ref-68">68</a>,<a href="#ref-69">69</a></sup>. Blocking caspase-8 activity, followed by interferon gamma (IFNγ) priming, rendered neutrophils sensitive to TNFR1-dependent necroptosis via the RIPK3-MLKL pathway, leading to NLRP3 activation<sup><a href="#ref-70">70</a></sup>. The finding that cell death pathways are distinctly regulated in neutrophils, as compared with other myeloid cells, signifies the importance of cell type on immune signalling pathways in orchestrating a co-ordinated inflammatory response.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d11054e679>Cellular activation and proliferation</h2><p class="" id=d11054e682>TNF is known to have widespread and profound effects on both the activation and the proliferation of different subsets of immune cells in several disease states. <i>In vitro</i> anti-TNF blockage, used in T-cell monocyte co-cultures of patients with the autoimmune disorder thrombocytopenia, produced a robust proliferation of the immunomodulatory regulatory T (Treg) cells<sup><a href="#ref-71">71</a></sup>; interestingly, this Treg cell expansion was dependent on TNFR2 and not TNFR1. Blockage of TNFR2 resulted in a robust expansion of Treg cells, whereas neutralisation of TNFR1 had no effect on this Treg cell expansion<sup><a href="#ref-71">71</a></sup>. Therefore, TNFR2 might be considered a potential novel therapeutic target for immunomodulation, not only in thrombocytopenia but also in other unrelated immune disorders associated with decreased levels of Treg cells, such as RA, AS, systemic lupus erythematosus (SLE), IBD, and psoriasis<sup><a href="#ref-72">72</a></sup>. For a recent review of anti-TNFR2 therapy, see Zou <i>et al</i>.<sup><a href="#ref-73">73</a></sup>.</p><p class="" id=d11054e708>Another report showed that inhibition of TNF signalling, by a number of anti-TNF biological treatments, primed naïve CD4<sup>+</sup> T cells towards a regulatory phenotype with high expression of IL-10 and reduced IFNγ production<sup><a href="#ref-74">74</a></sup>. Patients with cardiovascular disease often exhibit high levels of blood TNF, which are positively correlated with the formation of foam cells, and there are further repercussions for the development of plaques and blood clots<sup><a href="#ref-75">75</a></sup>. These observations were supported by both <i>in vitro</i> and <i>in vivo</i> experiments that confirmed that high levels of TNF enhanced the expression of adhesion molecules and scavenger receptors on blood monocytes<sup><a href="#ref-75">75</a></sup>. TNF has an important role, not only in immune cells but also in the regulation of circadian rhythms by the central nervous system. One study reported that TNF stimulation of the suprachiasmatic nucleus exerted an important influence on the regulation of circadian rhythms, through the activation of TNFR1 after lipopolysaccharide (LPS) inoculation, mainly during the early period of the night, when TNFR1 showed its highest expression<sup><a href="#ref-76">76</a></sup>. This regulation has novel implications for several disorders and might explain some of the observed disruption of circadian rhythms during disease<sup><a href="#ref-76">76</a>–<a href="#ref-78">78</a></sup>, perhaps due to higher expression of TNF in activated immune cells.</p><p class="" id=d11054e744>A20 has been shown to promote cell survival of CD4 T cells by initiation of autophagy via its inhibition of mammalian target of rapamycin (mTOR)<sup><a href="#ref-79">79</a></sup> as well as to restrain the development of Treg cells, as A20-deficient mice present with enlarged thymic and peripheral Treg cell compartments<sup><a href="#ref-80">80</a></sup>. A20 has also been shown to exert an important defence role against bacterial infections, as it enhances secondary CD8<sup>+</sup> T-cell responses but reduces the primary response<sup><a href="#ref-81">81</a></sup>. SHARPIN, a component of LUBAC, has a number of modulating effects on T cells; for example, defective SHARPIN results in a significant reduction in the overall population of Treg cells and their ability to function correctly<sup><a href="#ref-82">82</a></sup>. Furthermore, deficiency of SHARPIN leads to reduced numbers of CD4<sup>+</sup> CD25<sup>+</sup> FOXP3<sup>+</sup> Treg cells in the blood, spleen, lymph nodes, and thymus<sup><a href="#ref-83">83</a></sup>. HOIL-1, which is another component of LUBAC, has been reported to be cleaved by mucosa-associated lymphoid tissue lymphoma translocation 1 (MALT1), leading to its becoming a potent inhibitor of LUBAC-induced NF-κB signalling in activated T cells<sup><a href="#ref-84">84</a>–<a href="#ref-87">87</a></sup>; other NF-κB regulatory proteins that are cleaved by MALT1 include A20<sup><a href="#ref-88">88</a></sup>, RelB<sup><a href="#ref-89">89</a></sup>, and CYLD<sup><a href="#ref-90">90</a></sup>, not to mention the auto-proteolytic cleavage of MALT1<sup><a href="#ref-91">91</a></sup>.</p><p class="" id=d11054e804>A recent study focusing on innate immune cells showed the importance of TNF activation of these cells in cerebral tuberculosis, although neuron-derived TNF also plays a limited role<sup><a href="#ref-92">92</a></sup>. TNF has a ubiquitous influence on different cells and tissues and has an important role in the tumour microenvironment. A recent publication reported that regulation of the immunomodulatory check point programmed death-ligand 1 (PD-L1) in tumour-associated macrophages and monocytes was strongly increased by TNF in a B16 melanoma mouse model of disease<sup><a href="#ref-93">93</a></sup>. By using TNFR<sup>–/–</sup> mice (strain B6.129 S-Tnfrsf1a<sup>tm1Imx</sup> Tnfrsf1b<sup>tm1Imx</sup>/J), the researchers found a significant decrease in numbers of tumour-associated macrophages and dendritic cells expressing PD-L1 and an associated reduction in the size of the tumours<sup><a href="#ref-93">93</a></sup>. In a separate study, TNF was reported to activate the NF-κB signalling pathway and upregulate PD-L1 in human prostate and colon cancer cells, thereby promoting immunosuppression and favouring the tumour microenvironment<sup><a href="#ref-94">94</a></sup>. Immunotherapy has proven to be an effective option in the treatment of several cancers with high expression of PD-L1; thus, incorporating anti-TNF biologics into this therapeutic regimen may result in improved outcomes for certain types of cancers.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d11054e836>Immunometabolism</h2><p class="" id=d11054e839>The link between metabolism and immunity first became apparent in the 1980s, when macrophage-conditioned media, stimulated with LPS, was found to increase lipoprotein lipase expression and promote resistance to insulin in adipocytes<sup><a href="#ref-95">95</a>,<a href="#ref-96">96</a></sup>. It was later observed that obese rats expressed increased levels of TNF in their adipose tissue and that obese humans also expressed TNF at higher levels in their muscle tissue<sup><a href="#ref-97">97</a>–<a href="#ref-99">99</a></sup>. In obese rats, TNF inhibition led to improved metabolism of glucose and improved insulin sensitivity<sup><a href="#ref-100">100</a>,<a href="#ref-101">101</a></sup>; however, when TNF was administered, the opposite effects occurred<sup><a href="#ref-102">102</a>,<a href="#ref-103">103</a></sup>.</p><p class="" id=d11054e870>The essential glycolytic enzyme, glyceraldehyde 3-phosphate dehydrogenase (GAPDH), under low glycolysis conditions has been linked to regulation of the inflammatory response, as it binds to TNF mRNA in monocytes and macrophages and post-transcriptionally inhibits its production<sup><a href="#ref-104">104</a>,<a href="#ref-105">105</a></sup>, thus showing that the metabolic state of immune cells helps regulate various immune responses. Additionally, the product of GAPDH, nicotinamide adenine dinucleotide (NADH), significantly inhibited TNF secretion in macrophages<sup><a href="#ref-105">105</a></sup>.</p><p class="" id=d11054e884>The anti-inflammatory metabolite itaconate was found to inhibit TNF in an LPS-stimulated mouse model as well as in human peripheral blood mononuclear cells; however, no effects were observed in human macrophages<sup><a href="#ref-106">106</a></sup>. Immature monocyte-derived dendritic cells have a high expression of the extracellular succinate sensor, a G-protein-coupled receptor known as GPR91, and these cells were shown to have enhanced production of TNF due to succinate when stimulated with the TLR7 ligand imiquimod or the TLR3 ligand polyinosinic-polycytidylic acid (poly[I:C])<sup><a href="#ref-106">106</a></sup>. Macrophages have also been recognised to upregulate their expression of GPR91 and release succinate into the extracellular milieu under inflammatory signals, which may lead to exacerbations of RA, as rheumatoid joints have high levels of succinate present<sup><a href="#ref-107">107</a></sup>.</p><p class="" id=d11054e899>Cis-aconitate decarboxylase (CAD), the enzyme product of immune-responsive gene 1 (IRG1), catalyses the decarboxylation of cis-aconitate to produce itaconate, and this reaction is induced by heme oxygenase 1 (HO-1) activity. Carbon monoxide induction of HO-1 led to reduced TNF levels via upregulated IRG1 expression, demonstrating IRG1’s anti-inflammatory effects<sup><a href="#ref-108">108</a></sup>. Another glycolytic enzyme, alpha-enolase (ENO1), has been shown to have inflammatory effects when expressed on the surface of monocytes and macrophages by contributing to the production of inflammatory cytokines, such as TNF, in the synovium of patients with RA and also in the type II collagen model of arthritis<sup><a href="#ref-109">109</a></sup>. ENO1 also plays a role in both the induction and the function of Treg cells via the promotion of Foxp3 splicing<sup><a href="#ref-110">110</a></sup>.</p><p class="" id=d11054e915>A recent study showed that inhibition of complex II of the mitochondria reduces the production of TNF in macrophages<sup><a href="#ref-111">111</a></sup>, and another study demonstrated the importance of mitochondrial citrate carrier (CIC) in TNF-triggered inflammation, whereby the CIC is transcriptionally upregulated under TNF stimulation via NF-κB and plays an essential role in regulating the downstream production of nitric oxide and prostaglandins<sup><a href="#ref-112">112</a></sup>. In macrophages, citrate accumulation is essential for fatty acid synthesis, in a murine model of type 2 diabetes, which enhances inflammatory signalling through TNF production<sup><a href="#ref-113">113</a>,<a href="#ref-114">114</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d11054e936>Tumour necrosis factor signalling-related inflammatory disease</h2><p class="" id=d11054e939>Although TNF plays an essential role in health, it also exerts a double-edged sword effect in several disease states. Indeed, in 1999, mutations in the <i>TNFRSF1A</i> gene, encoding TNFR1, were found to be associated with episodic fevers and profound localised inflammation; consequently, TNFR1-associated periodic syndrome (TRAPS) was defined as one of the disease entities under the collective heading of autoinflammatory diseases<sup><a href="#ref-115">115</a></sup>. The term “autoinflammation” was used to refer to the increasing number of clinical disorders characterised by episodes of seemingly unprovoked inflammation in the absence of high autoantibodies titres or antigen-specific T lymphocytes. Anti-TNF therapy was used for the treatment of TRAPS with some initial success; however, a large number of these patients eventually become resistant to this treatment<sup><a href="#ref-116">116</a>,<a href="#ref-117">117</a></sup>, and an increasing number of reports subsequently revealed the clinical benefits of anti-IL-1β and/or anti-IL-6 therapy in the forms of canakinumab and tocilizumab, respectively<sup><a href="#ref-118">118</a>–<a href="#ref-123">123</a></sup>. The current standard treatment for the more severe cases of TRAPS is IL-1β blockade.</p><p class="" id=d11054e963>Recently, the scope of autoinflammation has been broadened to encompass some abnormalities of deubiquitination and redox homeostasis under the name of ubiquitination-associated autoinflammatory diseases (UADs). There are a number UADs, but only two are known to directly affect the TNF signalling pathway, namely otulipenia/OTULIN-related autoinflammatory syndrome (ORAS) and A20 haploinsufficiency (HA20)<sup><a href="#ref-124">124</a></sup>. The DUB OTULIN is an essential negative regulator of inflammation and prevention of autoimmunity involving the TNF pathway. Genetic alterations of DUBs have been associated with neurodegenerative diseases and cancers<sup><a href="#ref-125">125</a></sup>; also, two unrelated monogenic systemic inflammatory diseases have been associated with defective DUBs<sup><a href="#ref-124">124</a></sup>. Otulipenia is caused by loss-of-function mutations in the linear (Met-1) OTULIN with resulting dysregulation of the deubiquitination process<sup><a href="#ref-126">126</a>,<a href="#ref-127">127</a></sup>. Increased signalling in the canonical NF-κB pathway with overproduction of TNF, IL-1β, IL-6, IL-12, IL-18, and IFNγ in response to LPS stimulation was reported in these patients. Anti-TNF therapy was found to normalise markers of active inflammation, including C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), and control disease activity in otulipenia<sup><a href="#ref-124">124</a></sup>.</p><p class="" id=d11054e989>Loss-of-function mutations in the <i>TNFAIP3</i> gene, which codes for A20, result in the UAD disorder, HA20, so named because of loss of function of one of the copies of the <i>A20</i> gene, leading to early onset systemic inflammation and a disorder resembling Behçet’s disease<sup><a href="#ref-128">128</a></sup>; for a recent review of HA20, see Kadowaki <i>et al</i>.<sup><a href="#ref-129">129</a></sup>. Polymorphisms in TNFAIP3 have also been linked to RA, SLE, psoriasis, and CD susceptibility through genome-wide association studies<sup><a href="#ref-128">128</a>,<a href="#ref-130">130</a>–<a href="#ref-136">136</a></sup>. A20 function has also been associated with a protective role in RA, as it negatively regulates NLRP3 inflammasome activity<sup><a href="#ref-137">137</a></sup>.</p><p class="" id=d11054e1024>Keratinocyte-specific deletion of the LUBAC components HOIP or HOIL-1 results in a lethal inflammatory skin disease, caused by TNFR1-induced caspase-8-mediated apoptosis, that occurs independently of RIPK1 kinase activity<sup><a href="#ref-138">138</a></sup>. This differential effect in cell death pathway aetiology provides clues to the benefits of various treatment pathways. Interestingly, patients with LUBAC-inactivating germline mutations, such as HOIL-1 and HOIP mutations, also have primary immunodeficiency and autoinflammation<sup><a href="#ref-139">139</a>–<a href="#ref-141">141</a></sup>. Expression of TNFR1 in peripheral blood mononuclear cells from patients with RA has been positively correlated with the efficacy of therapies received<sup><a href="#ref-142">142</a></sup>; furthermore, the expression of both TNFR1 and 2 is downregulated in B cells of patients with RA compared with healthy controls<sup><a href="#ref-142">142</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d11054e1050>Summary</h2><p class="" id=d11054e1053>The identification of TNF and the development of anti-TNF therapies for associated disorders were revolutionary moments in disease research, resulting in vast improvement in the quality of life for patients with these debilitating diseases. With the ever-expanding understanding of TNF and its signalling pathways, it is hoped that the new research focus on combination therapies, and not just anti-TNF, will further improve these patients’ quality of life.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d11054e1 class=n-a></a><h2 class=main-title id=d11471>Grant information</h2><p>The authors are supported by a grant (SRC009) from the Cystic Fibrosis Trust. JH is partially supported by the Leeds Institute of Medical Research. SL-R is supported by CONACyT.</p><p> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </p></div><div class=back-section><a name=d11054e1060 class=n-a></a><h2 class=main-title id=d11054e1062>Acknowledgments</h2><p class="" id=d11054e1065>The authors would like to thank Chi Wong for his input into the completion of this review.</p></div><div class=back-section><a name=d11054e1069 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d11979>References</h2><div class="section ref-list"><a name=d11054e1069 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d11054e1076 class=n-a></a>Carswell EA, Old LJ, Kassel RL, <i> et al.</i>: An endotoxin-induced serum factor that causes necrosis of tumors. <i>Proc Natl Acad Sci U S A.</i> 1975; <b>72</b>(9): 3666–70. <a target=xrefwindow id=d11054e1087 href="http://www.ncbi.nlm.nih.gov/pubmed/1103152">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1090 href="https://doi.org/10.1073/pnas.72.9.3666">Publisher Full Text </a> | <a target=xrefwindow id=d11054e1094 href="http://www.ncbi.nlm.nih.gov/pmc/articles/433057">Free Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d11054e1103 class=n-a></a>Aggarwal BB, Moffat B, Harkins RN: Human lymphotoxin. Production by a lymphoblastoid cell line, purification, and initial characterization. <i>J Biol Chem.</i> 1984; <b>259</b>(1): 686–91. <a target=xrefwindow id=d11054e1111 href="http://www.ncbi.nlm.nih.gov/pubmed/6608523">PubMed Abstract </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d11054e1120 class=n-a></a>Seymour HE, Worsley A, Smith JM, <i> et al.</i>: Anti-TNF agents for rheumatoid arthritis. <i>Br J Clin Pharmacol.</i> 2001; <b>51</b>(3): 201–8. <a target=xrefwindow id=d11054e1131 href="http://www.ncbi.nlm.nih.gov/pubmed/11298065">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1134 href="https://doi.org/10.1046/j.1365-2125.2001.00321.x">Publisher Full Text </a> | <a target=xrefwindow id=d11054e1138 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2015031">Free Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d11054e1147 class=n-a></a>Ghosh S: Anti-TNF therapy in Crohn's disease. <i>Novartis Found Symp.</i> 2004; <b>263</b>: 193–205. <a target=xrefwindow id=d11054e1155 href="http://www.ncbi.nlm.nih.gov/pubmed/15669643">PubMed Abstract </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d11054e1164 class=n-a></a>Coates LC, Marzo-Ortega H, Bennett AN, <i> et al.</i>: Anti-TNF Therapy in Ankylosing Spondylitis: Insights for the Clinician. <i>Ther Adv Musculoskelet Dis.</i> 2010; <b>2</b>(1): 37–43. <a target=xrefwindow id=d11054e1175 href="http://www.ncbi.nlm.nih.gov/pubmed/22870436">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1178 href="https://doi.org/10.1177/1759720X09359728">Publisher Full Text </a> | <a target=xrefwindow id=d11054e1182 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3383467">Free Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d11054e1192 class=n-a></a>Kircik LH, Del Rosso JQ: Anti-TNF agents for the treatment of psoriasis. <i>J Drugs Dermatol.</i> 2009; <b>8</b>(6): 546–59. <a target=xrefwindow id=d11054e1200 href="http://www.ncbi.nlm.nih.gov/pubmed/19537380">PubMed Abstract </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d11054e1209 class=n-a></a>Deroose JP, Eggermont AM, van Geel AN, <i> et al.</i>: 20 years experience of TNF-based isolated limb perfusion for in-transit melanoma metastases: TNF dose matters. <i>Ann Surg Oncol.</i> 2012; <b>19</b>(2): 627–35. <a target=xrefwindow id=d11054e1220 href="http://www.ncbi.nlm.nih.gov/pubmed/21879272">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1223 href="https://doi.org/10.1245/s10434-011-2030-7">Publisher Full Text </a> | <a target=xrefwindow id=d11054e1227 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3264869">Free Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1023755"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e1236 class=n-a></a>Grivennikov SI, Tumanov AV, Liepinsh DJ, <i> et al.</i>: Distinct and nonredundant <i>in vivo</i> functions of TNF produced by t cells and macrophages/neutrophils: Protective and deleterious effects. <i>Immunity.</i> 2005; <b>22</b>(1): 93–104. <a target=xrefwindow id=d11054e1250 href="http://www.ncbi.nlm.nih.gov/pubmed/15664162">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1254 href="https://doi.org/10.1016/j.immuni.2004.11.016">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1023755">F1000 Recommendation</a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d11054e1267 class=n-a></a>Black RA, Rauch CT, Kozlosky CJ, <i> et al.</i>: A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. <i>Nature.</i> 1997; <b>385</b>(6618): 729–33. <a target=xrefwindow id=d11054e1278 href="http://www.ncbi.nlm.nih.gov/pubmed/9034190">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1281 href="https://doi.org/10.1038/385729a0">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d11054e1290 class=n-a></a>Faustman D, Davis M: TNF receptor 2 pathway: drug target for autoimmune diseases. <i>Nat Rev Drug Discov.</i> 2010; <b>9</b>(6): 482–93. <a target=xrefwindow id=d11054e1298 href="http://www.ncbi.nlm.nih.gov/pubmed/20489699">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1301 href="https://doi.org/10.1038/nrd3030">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d11054e1310 class=n-a></a>Carpentier I, Coornaert B, Beyaert R: Function and regulation of tumor necrosis factor receptor type 2. <i>Curr Med Chem.</i> 2004; <b>11</b>(16): 2205–12. <a target=xrefwindow id=d11054e1318 href="http://www.ncbi.nlm.nih.gov/pubmed/15279559">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1321 href="https://doi.org/10.2174/0929867043364694">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d11054e1331 class=n-a></a>Grell M, Douni E, Wajant H, <i> et al.</i>: The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. <i>Cell.</i> 1995; <b>83</b>(5): 793–802. <a target=xrefwindow id=d11054e1342 href="http://www.ncbi.nlm.nih.gov/pubmed/8521496">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1345 href="https://doi.org/10.1016/0092-8674(95)90192-2">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d11054e1354 class=n-a></a>Eissner G, Kolch W, Scheurich P: Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system. <i>Cytokine Growth Factor Rev.</i> 2004; <b>15</b>(5): 353–66. <a target=xrefwindow id=d11054e1362 href="http://www.ncbi.nlm.nih.gov/pubmed/15450251">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1365 href="https://doi.org/10.1016/j.cytogfr.2004.03.011">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d11054e1374 class=n-a></a>Tartaglia LA, Weber RF, Figari IS, <i> et al.</i>: The two different receptors for tumor necrosis factor mediate distinct cellular responses. <i>Proc Natl Acad Sci U S A.</i> 1991; <b>88</b>(20): 9292–6. <a target=xrefwindow id=d11054e1385 href="http://www.ncbi.nlm.nih.gov/pubmed/1718003">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1388 href="https://doi.org/10.1073/pnas.88.20.9292">Publisher Full Text </a> | <a target=xrefwindow id=d11054e1392 href="http://www.ncbi.nlm.nih.gov/pmc/articles/52700">Free Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d11054e1401 class=n-a></a>Hsu H, Xiong J, Goeddel DV: The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. <i>Cell.</i> 1995; <b>81</b>(4): 495–504. <a target=xrefwindow id=d11054e1409 href="http://www.ncbi.nlm.nih.gov/pubmed/7758105">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1412 href="https://doi.org/10.1016/0092-8674(95)90070-5">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d11054e1421 class=n-a></a>Rothe M, Sarma V, Dixit V, <i> et al.</i>: TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. <i>Science.</i> 1995; <b>269</b>(5229): 1424–7. <a target=xrefwindow id=d11054e1432 href="http://www.ncbi.nlm.nih.gov/pubmed/7544915">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1435 href="https://doi.org/10.1126/science.7544915">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d11054e1444 class=n-a></a>Pimentel-Muiños FX, Seed B: Regulated commitment of TNF receptor signaling: a molecular switch for death or activation. <i>Immunity.</i> 1999; <b>11</b>(6): 783–93. <a target=xrefwindow id=d11054e1452 href="http://www.ncbi.nlm.nih.gov/pubmed/10626900">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1455 href="https://doi.org/10.1016/S1074-7613(00)80152-1">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d11054e1465 class=n-a></a>Naudé PJ, den Boer JA, Luiten PG, <i> et al.</i>: Tumor necrosis factor receptor cross-talk. <i>FEBS J.</i> 2011; <b>278</b>(6): 888–98. <a target=xrefwindow id=d11054e1476 href="http://www.ncbi.nlm.nih.gov/pubmed/21232019">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1479 href="https://doi.org/10.1111/j.1742-4658.2011.08017.x">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d11054e1488 class=n-a></a>Sedger LM, McDermott MF: TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants - past, present and future. <i>Cytokine Growth Factor Rev.</i> 2014; <b>25</b>(4): 453–72. <a target=xrefwindow id=d11054e1496 href="http://www.ncbi.nlm.nih.gov/pubmed/25169849">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1499 href="https://doi.org/10.1016/j.cytogfr.2014.07.016">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d11054e1508 class=n-a></a>Ting AT, Pimentel-Muiños FX, Seed B: RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis. <i>EMBO J.</i> 1996; <b>15</b>(22): 6189–96. <a target=xrefwindow id=d11054e1516 href="http://www.ncbi.nlm.nih.gov/pubmed/8947041">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1519 href="https://doi.org/10.1002/j.1460-2075.1996.tb01007.x">Publisher Full Text </a> | <a target=xrefwindow id=d11054e1522 href="http://www.ncbi.nlm.nih.gov/pmc/articles/452440">Free Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d11054e1531 class=n-a></a>Hsu H, Huang J, Shu HB, <i> et al.</i>: TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. <i>Immunity.</i> 1996; <b>4</b>(4): 387–96. <a target=xrefwindow id=d11054e1542 href="http://www.ncbi.nlm.nih.gov/pubmed/8612133">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1545 href="https://doi.org/10.1016/s1074-7613(00)80252-6">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d11054e1554 class=n-a></a>Wajant H, Scheurich P: TNFR1-induced activation of the classical NF-κB pathway. <i>FEBS J.</i> 2011; <b>278</b>(6): 862–76. <a target=xrefwindow id=d11054e1562 href="http://www.ncbi.nlm.nih.gov/pubmed/21232017">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1565 href="https://doi.org/10.1111/j.1742-4658.2011.08015.x">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d11054e1574 class=n-a></a>Ting AT, Bertrand MJM: More to Life than NF-κB in TNFR1 Signaling. <i>Trends Immunol.</i> 2016; <b>37</b>(8): 535–45. <a target=xrefwindow id=d11054e1582 href="http://www.ncbi.nlm.nih.gov/pubmed/27424290">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1585 href="https://doi.org/10.1016/j.it.2016.06.002">Publisher Full Text </a> | <a target=xrefwindow id=d11054e1588 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5076853">Free Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d11054e1598 class=n-a></a>Brenner D, Blaser H, Mak TW: Regulation of tumour necrosis factor signalling: live or let die. <i>Nat Rev Immunol.</i> 2015; <b>15</b>(6): 362–74. <a target=xrefwindow id=d11054e1606 href="http://www.ncbi.nlm.nih.gov/pubmed/26008591">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1609 href="https://doi.org/10.1038/nri3834">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1014699"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e1618 class=n-a></a>Micheau O, Tschopp J: Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. <i>Cell.</i> 2003; <b>114</b>(2): 181–90. <a target=xrefwindow id=d11054e1626 href="http://www.ncbi.nlm.nih.gov/pubmed/12887920">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1629 href="https://doi.org/10.1016/S0092-8674(03)00521-X">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1014699">F1000 Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d11054e1642 class=n-a></a>Wang L, Du F, Wang X: TNF-alpha induces two distinct caspase-8 activation pathways. <i>Cell.</i> 2008; <b>133</b>(4): 693–703. <a target=xrefwindow id=d11054e1650 href="http://www.ncbi.nlm.nih.gov/pubmed/18485876">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1653 href="https://doi.org/10.1016/j.cell.2008.03.036">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d11054e1662 class=n-a></a>Pasparakis M, Vandenabeele P: Necroptosis and its role in inflammation. <i>Nature.</i> 2015; <b>517</b>(7534): 311–20. <a target=xrefwindow id=d11054e1670 href="http://www.ncbi.nlm.nih.gov/pubmed/25592536">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1673 href="https://doi.org/10.1038/nature14191">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/14267354"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e1682 class=n-a></a>Sun L, Wang H, Wang Z, <i> et al.</i>: Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. <i>Cell.</i> 2012; <b>148</b>(1–2): 213–27. <a target=xrefwindow id=d11054e1693 href="http://www.ncbi.nlm.nih.gov/pubmed/22265413">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1696 href="https://doi.org/10.1016/j.cell.2011.11.031">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/14267354">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726236012"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e1709 class=n-a></a>Swatek KN, Komander D: Ubiquitin modifications. <i>Cell Res.</i> 2016; <b>26</b>(4): 399–422. <a target=xrefwindow id=d11054e1717 href="http://www.ncbi.nlm.nih.gov/pubmed/27012465">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1720 href="https://doi.org/10.1038/cr.2016.39">Publisher Full Text </a> | <a target=xrefwindow id=d11054e1723 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4822133">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726236012">F1000 Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733037239"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e1737 class=n-a></a>Wu Y, Kang J, Zhang L, <i> et al.</i>: Ubiquitination regulation of inflammatory responses through NF-κB pathway. <i>Am J Transl Res.</i> 2018; <b>10</b>(3): 881–91. <a target=xrefwindow id=d11054e1748 href="http://www.ncbi.nlm.nih.gov/pubmed/29636878">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1751 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5883129">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733037239">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d11054e1764 class=n-a></a>Tada K, Okazaki T, Sakon S, <i> et al.</i>: Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-kappa B activation and protection from cell death. <i>J Biol Chem.</i> 2001; <b>276</b>(39): 36530–4. <a target=xrefwindow id=d11054e1775 href="http://www.ncbi.nlm.nih.gov/pubmed/11479302">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1778 href="https://doi.org/10.1074/jbc.M104837200">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d11054e1787 class=n-a></a>Varfolomeev E, Goncharov T, Fedorova AV, <i> et al.</i>: c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation. <i>J Biol Chem.</i> 2008; <b>283</b>(36): 24295–9. <a target=xrefwindow id=d11054e1798 href="http://www.ncbi.nlm.nih.gov/pubmed/18621737">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1801 href="https://doi.org/10.1074/jbc.C800128200">Publisher Full Text </a> | <a target=xrefwindow id=d11054e1805 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3259840">Free Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/2248959"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e1814 class=n-a></a>Haas TL, Emmerich CH, Gerlach B, <i> et al.</i>: Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. <i>Mol Cell.</i> 2009; <b>36</b>(5): 831–44. <a target=xrefwindow id=d11054e1825 href="http://www.ncbi.nlm.nih.gov/pubmed/20005846">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1828 href="https://doi.org/10.1016/j.molcel.2009.10.013">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/2248959">F1000 Recommendation</a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718088953"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e1841 class=n-a></a>Emmerich CH, Ordureau A, Strickson S, <i> et al.</i>: Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains. <i>Proc Natl Acad Sci U S A.</i> 2013; <b>110</b>(38): 15247–52. <a target=xrefwindow id=d11054e1852 href="http://www.ncbi.nlm.nih.gov/pubmed/23986494">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1855 href="https://doi.org/10.1073/pnas.1314715110">Publisher Full Text </a> | <a target=xrefwindow id=d11054e1859 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3780889">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718088953">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d11054e1872 class=n-a></a>Emmerich CH, Bakshi S, Kelsall IR, <i> et al.</i>: Lys63/Met1-hybrid ubiquitin chains are commonly formed during the activation of innate immune signalling. <i>Biochem Biophys Res Commun.</i> 2016; <b>474</b>(3): 452–61. <a target=xrefwindow id=d11054e1883 href="http://www.ncbi.nlm.nih.gov/pubmed/27133719">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1886 href="https://doi.org/10.1016/j.bbrc.2016.04.141">Publisher Full Text </a> | <a target=xrefwindow id=d11054e1890 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4880150">Free Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d11054e1900 class=n-a></a>Beg AA, Baltimore D: An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. <i>Science.</i> 1996; <b>274</b>(5288): 782–4. <a target=xrefwindow id=d11054e1908 href="http://www.ncbi.nlm.nih.gov/pubmed/8864118">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1911 href="https://doi.org/10.1126/science.274.5288.782">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d11054e1920 class=n-a></a>Gozzelino R, Sole C, Llecha N, <i> et al.</i>: BCL-X<sub>L</sub> regulates TNF-alpha-mediated cell death independently of NF-kappaB, FLIP and IAPs. <i>Cell Res.</i> 2008; <b>18</b>(10): 1020–36. <a target=xrefwindow id=d11054e1934 href="http://www.ncbi.nlm.nih.gov/pubmed/18591962">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1938 href="https://doi.org/10.1038/cr.2008.76">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d11054e1947 class=n-a></a>Tsuchiya Y, Nakabayashi O, Nakano H: FLIP the Switch: Regulation of Apoptosis and Necroptosis by cFLIP. <i>Int J Mol Sci.</i> 2015; <b>16</b>(12): 30321–41. <a target=xrefwindow id=d11054e1955 href="http://www.ncbi.nlm.nih.gov/pubmed/26694384">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1958 href="https://doi.org/10.3390/ijms161226232">Publisher Full Text </a> | <a target=xrefwindow id=d11054e1961 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4691174">Free Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d11054e1970 class=n-a></a>O'Donnell MA, Legarda-Addison D, Skountzos P, <i> et al.</i>: Ubiquitination of RIP1 regulates an NF-kappaB-independent cell-death switch in TNF signaling. <i>Curr Biol.</i> 2007; <b>17</b>(5): 418–24. <a target=xrefwindow id=d11054e1981 href="http://www.ncbi.nlm.nih.gov/pubmed/17306544">PubMed Abstract </a> | <a target=xrefwindow id=d11054e1984 href="https://doi.org/10.1016/j.cub.2007.01.027">Publisher Full Text </a> | <a target=xrefwindow id=d11054e1988 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1868513">Free Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1032203"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e1997 class=n-a></a>Ea CK, Deng L, Xia ZP, <i> et al.</i>: Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. <i>Mol Cell.</i> 2006; <b>22</b>(2): 245–57. <a target=xrefwindow id=d11054e2008 href="http://www.ncbi.nlm.nih.gov/pubmed/16603398">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2011 href="https://doi.org/10.1016/j.molcel.2006.03.026">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1032203">F1000 Recommendation</a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732691138"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e2024 class=n-a></a>Annibaldi A, Wicky John S, Vanden Berghe T, <i> et al.</i>: Ubiquitin-Mediated Regulation of RIPK1 Kinase Activity Independent of IKK and MK2. <i>Mol Cell.</i> 2018; <b>69</b>(4): 566–580.e5. <a target=xrefwindow id=d11054e2035 href="http://www.ncbi.nlm.nih.gov/pubmed/29452637">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2038 href="https://doi.org/10.1016/j.molcel.2018.01.027">Publisher Full Text </a> | <a target=xrefwindow id=d11054e2042 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5823975">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732691138">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1015002"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e2056 class=n-a></a>Kovalenko A, Chable-Bessia C, Cantarella G, <i> et al.</i>: The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. <i>Nature.</i> 2003; <b>424</b>(6950): 801–5. <a target=xrefwindow id=d11054e2067 href="http://www.ncbi.nlm.nih.gov/pubmed/12917691">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2070 href="https://doi.org/10.1038/nature01802">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1015002">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1123956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e2083 class=n-a></a>Bertrand MJ, Milutinovic S, Dickson KM, <i> et al.</i>: cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. <i>Mol Cell.</i> 2008; <b>30</b>(6): 689–700. <a target=xrefwindow id=d11054e2094 href="http://www.ncbi.nlm.nih.gov/pubmed/18570872">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2097 href="https://doi.org/10.1016/j.molcel.2008.05.014">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1123956">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/8885956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e2110 class=n-a></a>Oberst A, Dillon CP, Weinlich R, <i> et al.</i>: Catalytic activity of the caspase-8-FLIP<sub>L</sub> complex inhibits RIPK3-dependent necrosis. <i>Nature.</i> 2011; <b>471</b>(7338): 363–7. <a target=xrefwindow id=d11054e2124 href="http://www.ncbi.nlm.nih.gov/pubmed/21368763">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2128 href="https://doi.org/10.1038/nature09852">Publisher Full Text </a> | <a target=xrefwindow id=d11054e2131 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3077893">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/8885956">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d11054e2144 class=n-a></a>Park YC, Ye H, Hsia C, <i> et al.</i>: A novel mechanism of TRAF signaling revealed by structural and functional analyses of the TRADD-TRAF2 interaction. <i>Cell.</i> 2000; <b>101</b>(7): 777–87. <a target=xrefwindow id=d11054e2155 href="http://www.ncbi.nlm.nih.gov/pubmed/10892748">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2158 href="https://doi.org/10.1016/S0092-8674(00)80889-2">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d11054e2167 class=n-a></a>Ye H, Wu H: Thermodynamic characterization of the interaction between TRAF2 and tumor necrosis factor receptor peptides by isothermal titration calorimetry. <i>Proc Natl Acad Sci U S A.</i> 2000; <b>97</b>(16): 8961–6. <a target=xrefwindow id=d11054e2175 href="http://www.ncbi.nlm.nih.gov/pubmed/10908665">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2178 href="https://doi.org/10.1073/pnas.160241997">Publisher Full Text </a> | <a target=xrefwindow id=d11054e2181 href="http://www.ncbi.nlm.nih.gov/pmc/articles/16804">Free Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d11054e2190 class=n-a></a>Grech AP, Gardam S, Chan T, <i> et al.</i>: Tumor necrosis factor receptor 2 (TNFR2) signaling is negatively regulated by a novel, carboxyl-terminal TNFR-associated factor 2 (TRAF2)-binding site. <i>J Biol Chem.</i> 2005; <b>280</b>(36): 31572–81. <a target=xrefwindow id=d11054e2201 href="http://www.ncbi.nlm.nih.gov/pubmed/16020544">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2204 href="https://doi.org/10.1074/jbc.M504849200">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1012406"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e2214 class=n-a></a>Wertz IE, O'Rourke KM, Zhou H, <i> et al.</i>: De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. <i>Nature.</i> 2004; <b>430</b>(7000): 694–9. <a target=xrefwindow id=d11054e2225 href="http://www.ncbi.nlm.nih.gov/pubmed/15258597">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2228 href="https://doi.org/10.1038/nature02794">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1012406">F1000 Recommendation</a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d11054e2241 class=n-a></a>Lu TT, Onizawa M, Hammer GE, <i> et al.</i>: Dimerization and ubiquitin mediated recruitment of A20, a complex deubiquitinating enzyme. <i>Immunity.</i> 2013; <b>38</b>(5): 896–905. <a target=xrefwindow id=d11054e2252 href="http://www.ncbi.nlm.nih.gov/pubmed/23602765">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2255 href="https://doi.org/10.1016/j.immuni.2013.03.008">Publisher Full Text </a> | <a target=xrefwindow id=d11054e2259 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3665706">Free Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d11054e2268 class=n-a></a>Tokunaga F, Nishimasu H, Ishitani R, <i> et al.</i>: Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation. <i>EMBO J.</i> 2012; <b>31</b>(19): 3856–70. <a target=xrefwindow id=d11054e2279 href="http://www.ncbi.nlm.nih.gov/pubmed/23032187">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2282 href="https://doi.org/10.1038/emboj.2012.241">Publisher Full Text </a> | <a target=xrefwindow id=d11054e2286 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3463848">Free Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d11054e2295 class=n-a></a>Verhelst K, Carpentier I, Kreike M, <i> et al.</i>: A20 inhibits LUBAC-mediated NF-κB activation by binding linear polyubiquitin chains via its zinc finger 7. <i>EMBO J.</i> 2012; <b>31</b>(19): 3845–55. <a target=xrefwindow id=d11054e2306 href="http://www.ncbi.nlm.nih.gov/pubmed/23032186">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2309 href="https://doi.org/10.1038/emboj.2012.240">Publisher Full Text </a> | <a target=xrefwindow id=d11054e2313 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3463847">Free Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/4568987"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e2322 class=n-a></a>Shembade N, Ma A, Harhaj EW: Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes. <i>Science.</i> 2010; <b>327</b>(5969): 1135–9. <a target=xrefwindow id=d11054e2330 href="http://www.ncbi.nlm.nih.gov/pubmed/20185725">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2333 href="https://doi.org/10.1126/science.1182364">Publisher Full Text </a> | <a target=xrefwindow id=d11054e2336 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3025292">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/4568987">F1000 Recommendation</a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d11054e2349 class=n-a></a>Draber P, Kupka S, Reichert M, <i> et al.</i>: LUBAC-Recruited CYLD and A20 Regulate Gene Activation and Cell Death by Exerting Opposing Effects on Linear Ubiquitin in Signaling Complexes. <i>Cell Rep.</i> 2015; <b>13</b>(10): 2258–72. <a target=xrefwindow id=d11054e2360 href="http://www.ncbi.nlm.nih.gov/pubmed/26670046">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2363 href="https://doi.org/10.1016/j.celrep.2015.11.009">Publisher Full Text </a> | <a target=xrefwindow id=d11054e2367 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4688036">Free Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d11054e2377 class=n-a></a>Elliott PR, Nielsen SV, Marco-Casanova P, <i> et al.</i>: Molecular basis and regulation of OTULIN-LUBAC interaction. <i>Mol Cell.</i> 2014; <b>54</b>(3): 335–48. <a target=xrefwindow id=d11054e2388 href="http://www.ncbi.nlm.nih.gov/pubmed/24726323">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2391 href="https://doi.org/10.1016/j.molcel.2014.03.018">Publisher Full Text </a> | <a target=xrefwindow id=d11054e2395 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4017264">Free Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d11054e2404 class=n-a></a>Blake PW, Toro JR: Update of cylindromatosis gene (<i>CYLD</i>) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling. <i>Hum Mutat.</i> 2009; <b>30</b>(7): 1025–36. <a target=xrefwindow id=d11054e2415 href="http://www.ncbi.nlm.nih.gov/pubmed/19462465">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2418 href="https://doi.org/10.1002/humu.21024">Publisher Full Text </a> | <a target=xrefwindow id=d11054e2422 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3243308">Free Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733428665"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e2431 class=n-a></a>Amin P, Florez M, Najafov A, <i> et al.</i>: Regulation of a distinct activated RIPK1 intermediate bridging complex I and complex II in TNFα-mediated apoptosis. <i>Proc Natl Acad Sci U S A.</i> 2018; <b>115</b>(26): E5944–E5953. <a target=xrefwindow id=d11054e2442 href="http://www.ncbi.nlm.nih.gov/pubmed/29891719">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2445 href="https://doi.org/10.1073/pnas.1806973115">Publisher Full Text </a> | <a target=xrefwindow id=d11054e2449 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6042106">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733428665">F1000 Recommendation</a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1156989"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e2462 class=n-a></a>Hitomi J, Christofferson DE, Ng A, <i> et al.</i>: Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. <i>Cell.</i> 2008; <b>135</b>(7): 1311–23. <a target=xrefwindow id=d11054e2473 href="http://www.ncbi.nlm.nih.gov/pubmed/19109899">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2476 href="https://doi.org/10.1016/j.cell.2008.10.044">Publisher Full Text </a> | <a target=xrefwindow id=d11054e2480 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2621059">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1156989">F1000 Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d11054e2493 class=n-a></a>Dondelinger Y, Jouan-Lanhouet S, Divert T, <i> et al.</i>: NF-κB-Independent Role of IKKα/IKKβ in Preventing RIPK1 Kinase-Dependent Apoptotic and Necroptotic Cell Death during TNF Signaling. <i>Mol Cell.</i> 2015; <b>60</b>(1): 63–76. <a target=xrefwindow id=d11054e2504 href="http://www.ncbi.nlm.nih.gov/pubmed/26344099">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2507 href="https://doi.org/10.1016/j.molcel.2015.07.032">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/729275285"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e2516 class=n-a></a>Geng J, Ito Y, Shi L, <i> et al.</i>: Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis. <i>Nat Commun.</i> 2017; <b>8</b>(1): 359. <a target=xrefwindow id=d11054e2527 href="http://www.ncbi.nlm.nih.gov/pubmed/28842570">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2530 href="https://doi.org/10.1038/s41467-017-00406-w">Publisher Full Text </a> | <a target=xrefwindow id=d11054e2534 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5572456">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/729275285">F1000 Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732665127"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e2548 class=n-a></a>Meng H, Liu Z, Li X, <i> et al.</i>: Death-domain dimerization-mediated activation of RIPK1 controls necroptosis and RIPK1-dependent apoptosis. <i>Proc Natl Acad Sci U S A.</i> 2018; <b>115</b>(9): E2001–E2009. <a target=xrefwindow id=d11054e2559 href="http://www.ncbi.nlm.nih.gov/pubmed/29440439">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2562 href="https://doi.org/10.1073/pnas.1722013115">Publisher Full Text </a> | <a target=xrefwindow id=d11054e2566 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5834731">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732665127">F1000 Recommendation</a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d11054e2579 class=n-a></a>Jarosz-Griffiths HH, Noble E, Rushworth JV, <i> et al.</i>: Amyloid-β Receptors: The Good, the Bad, and the Prion Protein. <i>J Biol Chem.</i> 2016; <b>291</b>(7): 3174–83. <a target=xrefwindow id=d11054e2590 href="http://www.ncbi.nlm.nih.gov/pubmed/26719327">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2593 href="https://doi.org/10.1074/jbc.R115.702704">Publisher Full Text </a> | <a target=xrefwindow id=d11054e2597 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4751366">Free Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726933838"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e2606 class=n-a></a>Lin J, Kumari S, Kim C, <i> et al.</i>: RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation. <i>Nature.</i> 2016; <b>540</b>(7631): 124–128. <a target=xrefwindow id=d11054e2617 href="http://www.ncbi.nlm.nih.gov/pubmed/27819681">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2620 href="https://doi.org/10.1038/nature20558">Publisher Full Text </a> | <a target=xrefwindow id=d11054e2624 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5755685">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726933838">F1000 Recommendation</a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726933836"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e2637 class=n-a></a>Newton K, Wickliffe KE, Maltzman A, <i> et al.</i>: RIPK1 inhibits ZBP1-driven necroptosis during development. <i>Nature.</i> 2016; <b>540</b>(7631): 129–133. <a target=xrefwindow id=d11054e2648 href="http://www.ncbi.nlm.nih.gov/pubmed/27819682">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2651 href="https://doi.org/10.1038/nature20559">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726933836">F1000 Recommendation</a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726351517"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e2664 class=n-a></a>Newton K, Dugger DL, Maltzman A, <i> et al.</i>: RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury. <i>Cell Death Differ.</i> 2016; <b>23</b>(9): 1565–76. <a target=xrefwindow id=d11054e2675 href="http://www.ncbi.nlm.nih.gov/pubmed/27177019">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2678 href="https://doi.org/10.1038/cdd.2016.46">Publisher Full Text </a> | <a target=xrefwindow id=d11054e2682 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5072432">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726351517">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734010388"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e2695 class=n-a></a>Garcia-Carbonell R, Wong J, Kim JY, <i> et al.</i>: Elevated A20 promotes TNF-induced and RIPK1-dependent intestinal epithelial cell death. <i>Proc Natl Acad Sci U S A.</i> 2018; <b>115</b>(39): E9192–E9200. <a target=xrefwindow id=d11054e2706 href="http://www.ncbi.nlm.nih.gov/pubmed/30209212">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2709 href="https://doi.org/10.1073/pnas.1810584115">Publisher Full Text </a> | <a target=xrefwindow id=d11054e2713 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6166836">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734010388">F1000 Recommendation</a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725465117"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e2727 class=n-a></a>Onizawa M, Oshima S, Schulze-Topphoff U, <i> et al.</i>: The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis. <i>Nat Immunol.</i> 2015; <b>16</b>(6): 618–27. <a target=xrefwindow id=d11054e2738 href="http://www.ncbi.nlm.nih.gov/pubmed/25939025">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2741 href="https://doi.org/10.1038/ni.3172">Publisher Full Text </a> | <a target=xrefwindow id=d11054e2745 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4439357">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725465117">F1000 Recommendation</a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727747264"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e2758 class=n-a></a>Anderton H, Rickard JA, Varigos GA, <i> et al.</i>: Inhibitor of Apoptosis Proteins (IAPs) Limit RIPK1-Mediated Skin Inflammation. <i>J Invest Dermatol.</i> 2017; <b>137</b>(11): 2371–2379. <a target=xrefwindow id=d11054e2769 href="http://www.ncbi.nlm.nih.gov/pubmed/28647349">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2772 href="https://doi.org/10.1016/j.jid.2017.05.031">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727747264">F1000 Recommendation</a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d11054e2785 class=n-a></a>Lawlor KE, Khan N, Mildenhall A, <i> et al.</i>: RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL. <i>Nat Commun.</i> 2015; <b>6</b>: 6282. <a target=xrefwindow id=d11054e2796 href="http://www.ncbi.nlm.nih.gov/pubmed/25693118">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2799 href="https://doi.org/10.1038/ncomms7282">Publisher Full Text </a> | <a target=xrefwindow id=d11054e2803 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4346630">Free Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727215351"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e2812 class=n-a></a>Conos SA, Chen KW, De Nardo D, <i> et al.</i>: Active MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner. <i>Proc Natl Acad Sci U S A.</i> 2017; <b>114</b>(6): E961–E969. <a target=xrefwindow id=d11054e2823 href="http://www.ncbi.nlm.nih.gov/pubmed/28096356">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2826 href="https://doi.org/10.1073/pnas.1613305114">Publisher Full Text </a> | <a target=xrefwindow id=d11054e2830 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5307433">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727215351">F1000 Recommendation</a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733068955"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e2843 class=n-a></a>Chen KW, Lawlor KE, von Pein JB, <i> et al.</i>: Cutting Edge: Blockade of Inhibitor of Apoptosis Proteins Sensitizes Neutrophils to TNF- but Not Lipopolysaccharide-Mediated Cell Death and IL-1β Secretion. <i>J Immunol.</i> 2018; <b>200</b>(10): 3341–3346. <a target=xrefwindow id=d11054e2854 href="http://www.ncbi.nlm.nih.gov/pubmed/29661823">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2857 href="https://doi.org/10.4049/jimmunol.1701620">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733068955">F1000 Recommendation</a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d11054e2870 class=n-a></a>Zhong H, Bussel J, Yazdanbakhsh K: <i>In vitro</i> TNF blockade enhances <i>ex vivo</i> expansion of regulatory T cells in patients with immune thrombocytopenia. <i>Br J Haematol.</i> 2015; <b>168</b>(2): 274–83. <a target=xrefwindow id=d11054e2884 href="http://www.ncbi.nlm.nih.gov/pubmed/25252160">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2888 href="https://doi.org/10.1111/bjh.13126">Publisher Full Text </a> | <a target=xrefwindow id=d11054e2891 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5358513">Free Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733575286"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e2901 class=n-a></a>Shaikh F, He J, Bhadra P, <i> et al.</i>: TNF Receptor Type II as an Emerging Drug Target for the Treatment of Cancer, Autoimmune Diseases, and Graft-Versus-Host Disease: Current Perspectives and <i>In Silico</i> Search for Small Molecule Binders. <i>Front Immunol.</i> 2018; <b>9</b>: 1382. <a target=xrefwindow id=d11054e2915 href="http://www.ncbi.nlm.nih.gov/pubmed/29967617">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2919 href="https://doi.org/10.3389/fimmu.2018.01382">Publisher Full Text </a> | <a target=xrefwindow id=d11054e2922 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6015900">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733575286">F1000 Recommendation</a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d11054e2935 class=n-a></a>Zou H, Li R, Hu H, <i> et al.</i>: Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents. <i>Front Immunol.</i> 2018; <b>9</b>: 594. <a target=xrefwindow id=d11054e2946 href="http://www.ncbi.nlm.nih.gov/pubmed/29632537">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2949 href="https://doi.org/10.3389/fimmu.2018.00594">Publisher Full Text </a> | <a target=xrefwindow id=d11054e2953 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5879105">Free Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d11054e2962 class=n-a></a>Boks MA, Kager-Groenland JR, Mousset CM, <i> et al.</i>: Inhibition of TNF receptor signaling by anti-TNFα biologicals primes naïve CD4<sup>+</sup> T cells towards IL-10<sup>+</sup> T cells with a regulatory phenotype and function. <i>Clin Immunol.</i> 2014; <b>151</b>(2): 136–45. <a target=xrefwindow id=d11054e2980 href="http://www.ncbi.nlm.nih.gov/pubmed/24568737">PubMed Abstract </a> | <a target=xrefwindow id=d11054e2983 href="https://doi.org/10.1016/j.clim.2014.02.008">Publisher Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d11054e2992 class=n-a></a>Zhu M, Lei L, Zhu Z, <i> et al.</i>: Excess TNF-α in the blood activates monocytes with the potential to directly form cholesteryl ester-laden cells. <i>Acta Biochim Biophys Sin (Shanghai).</i> 2015; <b>47</b>(11): 899–907. <a target=xrefwindow id=d11054e3003 href="http://www.ncbi.nlm.nih.gov/pubmed/26373842">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3006 href="https://doi.org/10.1093/abbs/gmv092">Publisher Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d11054e3015 class=n-a></a>Paladino N, Mul Fedele ML, Duhart JM, <i> et al.</i>: Modulation of mammalian circadian rhythms by tumor necrosis factor-α. <i>Chronobiol Int.</i> 2014; <b>31</b>(5): 668–79. <a target=xrefwindow id=d11054e3026 href="http://www.ncbi.nlm.nih.gov/pubmed/24527954">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3029 href="https://doi.org/10.3109/07420528.2014.886588">Publisher Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733749200"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e3038 class=n-a></a>Abreu M, Basti A, Genov N, <i> et al.</i>: The reciprocal interplay between TNFα and the circadian clock impacts on cell proliferation and migration in Hodgkin lymphoma cells. <i>Sci Rep.</i> 2018; <b>8</b>(1): 11474. <a target=xrefwindow id=d11054e3049 href="http://www.ncbi.nlm.nih.gov/pubmed/30065253">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3052 href="https://doi.org/10.1038/s41598-018-29847-z">Publisher Full Text </a> | <a target=xrefwindow id=d11054e3056 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6068144">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733749200">F1000 Recommendation</a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732248841"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e3070 class=n-a></a>Yoshida K, Nakai A, Kaneshiro K, <i> et al.</i>: TNF-α induces expression of the circadian clock gene <i>Bmal1</i> via dual calcium-dependent pathways in rheumatoid synovial cells. <i>Biochem Biophys Res Commun.</i> 2018; <b>495</b>(2): 1675–1680. <a target=xrefwindow id=d11054e3084 href="http://www.ncbi.nlm.nih.gov/pubmed/29217191">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3088 href="https://doi.org/10.1016/j.bbrc.2017.12.015">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732248841">F1000 Recommendation</a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d11054e3101 class=n-a></a>Matsuzawa Y, Oshima S, Takahara M, <i> et al.</i>: TNFAIP3 promotes survival of CD4 T cells by restricting MTOR and promoting autophagy. <i>Autophagy.</i> 2015; <b>11</b>(7): 1052–62. <a target=xrefwindow id=d11054e3112 href="http://www.ncbi.nlm.nih.gov/pubmed/26043155">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3115 href="https://doi.org/10.1080/15548627.2015.1055439">Publisher Full Text </a> | <a target=xrefwindow id=d11054e3119 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4590588">Free Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/729275338"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e3128 class=n-a></a>Fischer JC, Otten V, Kober M, <i> et al.</i>: A20 Restrains Thymic Regulatory T Cell Development. <i>J Immunol.</i> 2017; <b>199</b>(7): 2356–2365. <a target=xrefwindow id=d11054e3139 href="http://www.ncbi.nlm.nih.gov/pubmed/28842469">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3142 href="https://doi.org/10.4049/jimmunol.1602102">Publisher Full Text </a> | <a target=xrefwindow id=d11054e3146 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5617121">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/729275338">F1000 Recommendation</a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727137491"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e3159 class=n-a></a>Just S, Nishanth G, Buchbinder JH, <i> et al.</i>: A20 Curtails Primary but Augments Secondary CD8<sup>+</sup> T Cell Responses in Intracellular Bacterial Infection. <i>Sci Rep.</i> 2016; <b>6</b>: 39796. <a target=xrefwindow id=d11054e3173 href="http://www.ncbi.nlm.nih.gov/pubmed/28004776">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3177 href="https://doi.org/10.1038/srep39796">Publisher Full Text </a> | <a target=xrefwindow id=d11054e3180 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5177869">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727137491">F1000 Recommendation</a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726111775"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e3193 class=n-a></a>Park Y, Jin HS, Lopez J, <i> et al.</i>: SHARPIN controls regulatory T cells by negatively modulating the T cell antigen receptor complex. <i>Nat Immunol.</i> 2016; <b>17</b>(3): 286–96. <a target=xrefwindow id=d11054e3204 href="http://www.ncbi.nlm.nih.gov/pubmed/26829767">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3207 href="https://doi.org/10.1038/ni.3352">Publisher Full Text </a> | <a target=xrefwindow id=d11054e3211 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4919114">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726111775">F1000 Recommendation</a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d11054e3224 class=n-a></a>Redecke V, Chaturvedi V, Kuriakose J, <i> et al.</i>: SHARPIN controls the development of regulatory T cells. <i>Immunology.</i> 2016; <b>148</b>(2): 216–26. <a target=xrefwindow id=d11054e3235 href="http://www.ncbi.nlm.nih.gov/pubmed/26931177">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3238 href="https://doi.org/10.1111/imm.12604">Publisher Full Text </a> | <a target=xrefwindow id=d11054e3242 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4863576">Free Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d11054e3252 class=n-a></a>Elton L, Carpentier I, Staal J, <i> et al.</i>: MALT1 cleaves the E3 ubiquitin ligase HOIL-1 in activated T cells, generating a dominant negative inhibitor of LUBAC-induced NF-κB signaling. <i>FEBS J.</i> 2016; <b>283</b>(3): 403–12. <a target=xrefwindow id=d11054e3263 href="http://www.ncbi.nlm.nih.gov/pubmed/26573773">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3266 href="https://doi.org/10.1111/febs.13597">Publisher Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725906761"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e3275 class=n-a></a>Klein T, Fung SY, Renner F, <i> et al.</i>: The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-κB signalling. <i>Nat Commun.</i> 2015; <b>6</b>: 8777. <a target=xrefwindow id=d11054e3286 href="http://www.ncbi.nlm.nih.gov/pubmed/26525107">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3289 href="https://doi.org/10.1038/ncomms9777">Publisher Full Text </a> | <a target=xrefwindow id=d11054e3293 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4659944">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725906761">F1000 Recommendation</a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d11054e3306 class=n-a></a>Douanne T, Gavard J, Bidère N: The paracaspase MALT1 cleaves the LUBAC subunit HOIL1 during antigen receptor signaling. <i>J Cell Sci.</i> 2016; <b>129</b>(9): 1775–80. <a target=xrefwindow id=d11054e3314 href="http://www.ncbi.nlm.nih.gov/pubmed/27006117">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3317 href="https://doi.org/10.1242/jcs.185025">Publisher Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d11054e3326 class=n-a></a>Hailfinger S, Schmitt A, Schulze-Osthoff K: The paracaspase MALT1 dampens NF-κB signalling by cleaving the LUBAC subunit HOIL-1. <i>FEBS J.</i> 2016; <b>283</b>(3): 400–2. <a target=xrefwindow id=d11054e3334 href="http://www.ncbi.nlm.nih.gov/pubmed/26716947">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3337 href="https://doi.org/10.1111/febs.13639">Publisher Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d11054e3346 class=n-a></a>Coornaert B, Baens M, Heyninck K, <i> et al.</i>: T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20. <i>Nat Immunol.</i> 2008; <b>9</b>(3): 263–71. <a target=xrefwindow id=d11054e3357 href="http://www.ncbi.nlm.nih.gov/pubmed/18223652">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3360 href="https://doi.org/10.1038/ni1561">Publisher Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13445989"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e3369 class=n-a></a>Hailfinger S, Nogai H, Pelzer C, <i> et al.</i>: Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines. <i>Proc Natl Acad Sci U S A.</i> 2011; <b>108</b>(35): 14596–601. <a target=xrefwindow id=d11054e3380 href="http://www.ncbi.nlm.nih.gov/pubmed/21873235">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3383 href="https://doi.org/10.1073/pnas.1105020108">Publisher Full Text </a> | <a target=xrefwindow id=d11054e3387 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3167514">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13445989">F1000 Recommendation</a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d11054e3401 class=n-a></a>Staal J, Driege Y, Bekaert T, <i> et al.</i>: T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1. <i>EMBO J.</i> 2011; <b>30</b>(9): 1742–52. <a target=xrefwindow id=d11054e3412 href="http://www.ncbi.nlm.nih.gov/pubmed/21448133">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3415 href="https://doi.org/10.1038/emboj.2011.85">Publisher Full Text </a> | <a target=xrefwindow id=d11054e3419 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3101995">Free Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d11054e3428 class=n-a></a>Baens M, Bonsignore L, Somers R, <i> et al.</i>: MALT1 auto-proteolysis is essential for NF-κB-dependent gene transcription in activated lymphocytes. <i>PLoS One.</i> 2014; <b>9</b>(8): e103774. <a target=xrefwindow id=d11054e3439 href="http://www.ncbi.nlm.nih.gov/pubmed/25105596">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3442 href="https://doi.org/10.1371/journal.pone.0103774">Publisher Full Text </a> | <a target=xrefwindow id=d11054e3446 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4126661">Free Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d11054e3455 class=n-a></a>Francisco NM, Hsu NJ, Keeton R, <i> et al.</i>: TNF-dependent regulation and activation of innate immune cells are essential for host protection against cerebral tuberculosis. <i>J Neuroinflammation.</i> 2015; <b>12</b>: 125. <a target=xrefwindow id=d11054e3466 href="http://www.ncbi.nlm.nih.gov/pubmed/26112704">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3469 href="https://doi.org/10.1186/s12974-015-0345-1">Publisher Full Text </a> | <a target=xrefwindow id=d11054e3473 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4488051">Free Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727302267"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e3482 class=n-a></a>Hartley G, Regan D, Guth A, <i> et al.</i>: Regulation of PD-L1 expression on murine tumor-associated monocytes and macrophages by locally produced TNF-α. <i>Cancer Immunol Immunother.</i> 2017; <b>66</b>(4): 523–35. <a target=xrefwindow id=d11054e3493 href="http://www.ncbi.nlm.nih.gov/pubmed/28184968">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3496 href="https://doi.org/10.1007/s00262-017-1955-5">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727302267">F1000 Recommendation</a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727640291"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e3509 class=n-a></a>Wang X, Yang L, Huang F, <i> et al.</i>: Inflammatory cytokines IL-17 and TNF-α up-regulate PD-L1 expression in human prostate and colon cancer cells. <i>Immunol Lett.</i> 2017; <b>184</b>: 7–14. <a target=xrefwindow id=d11054e3520 href="http://www.ncbi.nlm.nih.gov/pubmed/28223102">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3523 href="https://doi.org/10.1016/j.imlet.2017.02.006">Publisher Full Text </a> | <a target=xrefwindow id=d11054e3527 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5362328">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727640291">F1000 Recommendation</a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a name=d11054e3540 class=n-a></a>Pekala P, Kawakami M, Vine W, <i> et al.</i>: Studies of insulin resistance in adipocytes induced by macrophage mediator. <i>J Exp Med.</i> 1983; <b>157</b>(4): 1360–5. <a target=xrefwindow id=d11054e3551 href="http://www.ncbi.nlm.nih.gov/pubmed/6833952">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3554 href="https://doi.org/10.1084/jem.157.4.1360">Publisher Full Text </a> | <a target=xrefwindow id=d11054e3558 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2186991">Free Full Text </a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a name=d11054e3568 class=n-a></a>Mahoney JR Jr, Beutler BA, Le Trang N, <i> et al.</i>: Lipopolysaccharide-treated RAW 264.7 cells produce a mediator that inhibits lipoprotein lipase in 3T3-L1 cells. <i>J Immunol.</i> 1985; <b>134</b>(3): 1673–5. <a target=xrefwindow id=d11054e3579 href="http://www.ncbi.nlm.nih.gov/pubmed/3968430">PubMed Abstract </a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d11054e3588 class=n-a></a>Kern PA, Saghizadeh M, Ong JM, <i> et al.</i>: The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. <i>J Clin Invest.</i> 1995; <b>95</b>(5): 2111–9. <a target=xrefwindow id=d11054e3599 href="http://www.ncbi.nlm.nih.gov/pubmed/7738178">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3602 href="https://doi.org/10.1172/JCI117899">Publisher Full Text </a> | <a target=xrefwindow id=d11054e3606 href="http://www.ncbi.nlm.nih.gov/pmc/articles/295809">Free Full Text </a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a name=d11054e3615 class=n-a></a>Hotamisligil GS, Arner P, Caro JF, <i> et al.</i>: Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. <i>J Clin Invest.</i> 1995; <b>95</b>(5): 2409–15. <a target=xrefwindow id=d11054e3626 href="http://www.ncbi.nlm.nih.gov/pubmed/7738205">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3629 href="https://doi.org/10.1172/JCI117936">Publisher Full Text </a> | <a target=xrefwindow id=d11054e3633 href="http://www.ncbi.nlm.nih.gov/pmc/articles/295872">Free Full Text </a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d11054e3642 class=n-a></a>Saghizadeh M, Ong JM, Garvey WT, <i> et al.</i>: The expression of TNF alpha by human muscle. Relationship to insulin resistance. <i>J Clin Invest.</i> 1996; <b>97</b>(4): 1111–6. <a target=xrefwindow id=d11054e3653 href="http://www.ncbi.nlm.nih.gov/pubmed/8613535">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3656 href="https://doi.org/10.1172/JCI118504">Publisher Full Text </a> | <a target=xrefwindow id=d11054e3660 href="http://www.ncbi.nlm.nih.gov/pmc/articles/507159">Free Full Text </a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a name=d11054e3669 class=n-a></a>Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. <i>Science.</i> 1993; <b>259</b>(5091): 87–91. <a target=xrefwindow id=d11054e3677 href="http://www.ncbi.nlm.nih.gov/pubmed/7678183">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3680 href="https://doi.org/10.1126/science.7678183">Publisher Full Text </a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a name=d11054e3689 class=n-a></a>Borst SE, Bagby GJ: Neutralization of tumor necrosis factor reverses age-induced impairment of insulin responsiveness in skeletal muscle of Sprague-Dawley rats. <i>Metabolism.</i> 2002; <b>51</b>(8): 1061–4. <a target=xrefwindow id=d11054e3697 href="http://www.ncbi.nlm.nih.gov/pubmed/12145782">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3700 href="https://doi.org/10.1053/meta.2002.34043">Publisher Full Text </a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a name=d11054e3710 class=n-a></a>Ling PR, Bistrian BR, Mendez B, <i> et al.</i>: Effects of systemic infusions of endotoxin, tumor necrosis factor, and interleukin-1 on glucose metabolism in the rat: relationship to endogenous glucose production and peripheral tissue glucose uptake. <i>Metabolism.</i> 1994; <b>43</b>(3): 279–84. <a target=xrefwindow id=d11054e3721 href="http://www.ncbi.nlm.nih.gov/pubmed/8139474">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3724 href="https://doi.org/10.1016/0026-0495(94)90093-0">Publisher Full Text </a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a name=d11054e3733 class=n-a></a>Miles PD, Romeo OM, Higo K, <i> et al.</i>: TNF-alpha-induced insulin resistance <i>in vivo</i> and its prevention by troglitazone. <i>Diabetes.</i> 1997; <b>46</b>(11): 1678–83. <a target=xrefwindow id=d11054e3747 href="http://www.ncbi.nlm.nih.gov/pubmed/9356012">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3751 href="https://doi.org/10.2337/diab.46.11.1678">Publisher Full Text </a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726121049"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e3759 class=n-a></a>Millet P, Vachharajani V, McPhail L, <i> et al.</i>: GAPDH Binding to TNF-α mRNA Contributes to Posttranscriptional Repression in Monocytes: A Novel Mechanism of Communication between Inflammation and Metabolism. <i>J Immunol.</i> 2016; <b>196</b>(6): 2541–51. <a target=xrefwindow id=d11054e3770 href="http://www.ncbi.nlm.nih.gov/pubmed/26843329">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3773 href="https://doi.org/10.4049/jimmunol.1501345">Publisher Full Text </a> | <a target=xrefwindow id=d11054e3777 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4779706">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726121049">F1000 Recommendation</a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/728644365"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e3790 class=n-a></a>Nakano T, Goto S, Takaoka Y, <i> et al.</i>: A novel moonlight function of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) for immunomodulation. <i>Biofactors.</i> 2018; <b>44</b>(6): 597–608. <a target=xrefwindow id=d11054e3801 href="http://www.ncbi.nlm.nih.gov/pubmed/28753256">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3804 href="https://doi.org/10.1002/biof.1379">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/728644365">F1000 Recommendation</a></span></li><li><a name=ref-106 class=n-a></a><span class=label>106. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732913653"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e3817 class=n-a></a>Mills EL, Ryan DG, Prag HA, <i> et al.</i>: Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. <i>Nature.</i> 2018; <b>556</b>(7699): 113–7. <a target=xrefwindow id=d11054e3828 href="http://www.ncbi.nlm.nih.gov/pubmed/29590092">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3831 href="https://doi.org/10.1038/nature25986">Publisher Full Text </a> | <a target=xrefwindow id=d11054e3835 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6047741">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732913653">F1000 Recommendation</a></span></li><li><a name=ref-107 class=n-a></a><span class=label>107. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726603084"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e3848 class=n-a></a>Littlewood-Evans A, Sarret S, Apfel V, <i> et al.</i>: GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis. <i>J Exp Med.</i> 2016; <b>213</b>(9): 1655–62. <a target=xrefwindow id=d11054e3859 href="http://www.ncbi.nlm.nih.gov/pubmed/27481132">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3862 href="https://doi.org/10.1084/jem.20160061">Publisher Full Text </a> | <a target=xrefwindow id=d11054e3866 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4995082">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726603084">F1000 Recommendation</a></span></li><li><a name=ref-108 class=n-a></a><span class=label>108. </span>&nbsp;<span class=citation><a name=d11054e3880 class=n-a></a>Jamal Uddin M, Joe Y, Kim SK, <i> et al.</i>: IRG1 induced by heme oxygenase-1/carbon monoxide inhibits LPS-mediated sepsis and pro-inflammatory cytokine production. <i>Cell Mol Immunol.</i> 2015; <b>13</b>(2): 170–9. <a target=xrefwindow id=d11054e3891 href="http://www.ncbi.nlm.nih.gov/pubmed/25640654">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3894 href="https://doi.org/10.1038/cmi.2015.02">Publisher Full Text </a> | <a target=xrefwindow id=d11054e3898 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4786624">Free Full Text </a></span></li><li><a name=ref-109 class=n-a></a><span class=label>109. </span>&nbsp;<span class=citation><a name=d11054e3907 class=n-a></a>Bae S, Kim H, Lee N, <i> et al.</i>: α-Enolase expressed on the surfaces of monocytes and macrophages induces robust synovial inflammation in rheumatoid arthritis. <i>J Immunol.</i> 2012; <b>189</b>(1): 365–72. <a target=xrefwindow id=d11054e3918 href="http://www.ncbi.nlm.nih.gov/pubmed/22623332">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3921 href="https://doi.org/10.4049/jimmunol.1102073">Publisher Full Text </a></span></li><li><a name=ref-110 class=n-a></a><span class=label>110. </span>&nbsp;<span class=citation><a name=d11054e3930 class=n-a></a>De Rosa V, Galgani M, Porcellini A, <i> et al.</i>: Glycolysis controls the induction of human regulatory T cells by modulating the expression of <i>FOXP3</i> exon 2 splicing variants. <i>Nat Immunol.</i> 2015; <b>16</b>(11): 1174–84. <a target=xrefwindow id=d11054e3944 href="http://www.ncbi.nlm.nih.gov/pubmed/26414764">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3948 href="https://doi.org/10.1038/ni.3269">Publisher Full Text </a> | <a target=xrefwindow id=d11054e3951 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4868085">Free Full Text </a></span></li><li><a name=ref-111 class=n-a></a><span class=label>111. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732292335"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e3960 class=n-a></a>Davies LC, Rice CM, Palmieri EM, <i> et al.</i>: Peritoneal tissue-resident macrophages are metabolically poised to engage microbes using tissue-niche fuels. <i>Nat Commun.</i> 2017; <b>8</b>(1): 2074. <a target=xrefwindow id=d11054e3971 href="http://www.ncbi.nlm.nih.gov/pubmed/29234000">PubMed Abstract </a> | <a target=xrefwindow id=d11054e3974 href="https://doi.org/10.1038/s41467-017-02092-0">Publisher Full Text </a> | <a target=xrefwindow id=d11054e3978 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5727035">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732292335">F1000 Recommendation</a></span></li><li><a name=ref-112 class=n-a></a><span class=label>112. </span>&nbsp;<span class=citation><a name=d11054e3991 class=n-a></a>Infantino V, Iacobazzi V, Menga A, <i> et al.</i>: A key role of the mitochondrial citrate carrier (<i>SLC25A1</i>) in TNFα- and IFNγ-triggered inflammation. <i>Biochim Biophys Acta.</i> 2014; <b>1839</b>(11): 1217–25. <a target=xrefwindow id=d11054e4005 href="http://www.ncbi.nlm.nih.gov/pubmed/25072865">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4009 href="https://doi.org/10.1016/j.bbagrm.2014.07.013">Publisher Full Text </a> | <a target=xrefwindow id=d11054e4012 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4346166">Free Full Text </a></span></li><li><a name=ref-113 class=n-a></a><span class=label>113. </span>&nbsp;<span class=citation><a name=d11054e4021 class=n-a></a>Moon JS, Lee S, Park MA, <i> et al.</i>: UCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis. <i>J Clin Invest.</i> 2015; <b>125</b>(2): 665–80. <a target=xrefwindow id=d11054e4032 href="http://www.ncbi.nlm.nih.gov/pubmed/25574840">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4035 href="https://doi.org/10.1172/JCI78253">Publisher Full Text </a> | <a target=xrefwindow id=d11054e4039 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4319445">Free Full Text </a></span></li><li><a name=ref-114 class=n-a></a><span class=label>114. </span>&nbsp;<span class=citation><a name=d11054e4049 class=n-a></a>Wei X, Song H, Yin L, <i> et al.</i>: Fatty acid synthesis configures the plasma membrane for inflammation in diabetes. <i>Nature.</i> 2016; <b>539</b>(7628): 294–8. <a target=xrefwindow id=d11054e4060 href="http://www.ncbi.nlm.nih.gov/pubmed/27806377">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4063 href="https://doi.org/10.1038/nature20117">Publisher Full Text </a> | <a target=xrefwindow id=d11054e4067 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5671339">Free Full Text </a></span></li><li><a name=ref-115 class=n-a></a><span class=label>115. </span>&nbsp;<span class=citation><a name=d11054e4076 class=n-a></a>McDermott MF, Aksentijevich I, Galon J, <i> et al.</i>: Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. <i>Cell.</i> 1999; <b>97</b>(1): 133–44. <a target=xrefwindow id=d11054e4087 href="http://www.ncbi.nlm.nih.gov/pubmed/10199409">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4090 href="https://doi.org/10.1016/S0092-8674(00)80721-7">Publisher Full Text </a></span></li><li><a name=ref-116 class=n-a></a><span class=label>116. </span>&nbsp;<span class=citation><a name=d11054e4099 class=n-a></a>Quillinan N, Mannion G, Mohammad A, <i> et al.</i>: Failure of sustained response to etanercept and refractoriness to anakinra in patients with T50M TNF-receptor-associated periodic syndrome. <i>Ann Rheum Dis.</i> 2011; <b>70</b>(9): 1692–3. <a target=xrefwindow id=d11054e4110 href="http://www.ncbi.nlm.nih.gov/pubmed/21378401">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4113 href="https://doi.org/10.1136/ard.2010.144279">Publisher Full Text </a></span></li><li><a name=ref-117 class=n-a></a><span class=label>117. </span>&nbsp;<span class=citation><a name=d11054e4122 class=n-a></a>Bulua AC, Mogul DB, Aksentijevich I, <i> et al.</i>: Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: a prospective, open-label, dose-escalation study. <i>Arthritis Rheum.</i> 2012; <b>64</b>(3): 908–13. <a target=xrefwindow id=d11054e4133 href="http://www.ncbi.nlm.nih.gov/pubmed/22006113">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4136 href="https://doi.org/10.1002/art.33416">Publisher Full Text </a> | <a target=xrefwindow id=d11054e4140 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3882089">Free Full Text </a></span></li><li><a name=ref-118 class=n-a></a><span class=label>118. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726588506"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e4149 class=n-a></a>Torene R, Nirmala N, Obici L, <i> et al.</i>: Canakinumab reverses overexpression of inflammatory response genes in tumour necrosis factor receptor-associated periodic syndrome. <i>Ann Rheum Dis.</i> 2017; <b>76</b>(1): 303–9. <a target=xrefwindow id=d11054e4160 href="http://www.ncbi.nlm.nih.gov/pubmed/27474763">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4163 href="https://doi.org/10.1136/annrheumdis-2016-209335">Publisher Full Text </a> | <a target=xrefwindow id=d11054e4167 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5264306">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726588506">F1000 Recommendation</a></span></li><li><a name=ref-119 class=n-a></a><span class=label>119. </span>&nbsp;<span class=citation><a name=d11054e4180 class=n-a></a>Gattorno M, Obici L, Cattalini M, <i> et al.</i>: Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study. <i>Ann Rheum Dis.</i> 2016; <b>76</b>(1): 173–8. <a target=xrefwindow id=d11054e4191 href="http://www.ncbi.nlm.nih.gov/pubmed/27269295">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4194 href="https://doi.org/10.1136/annrheumdis-2015-209031">Publisher Full Text </a> | <a target=xrefwindow id=d11054e4198 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5264215">Free Full Text </a></span></li><li><a name=ref-120 class=n-a></a><span class=label>120. </span>&nbsp;<span class=citation><a name=d11054e4208 class=n-a></a>La Torre F, Muratore M, Vitale A, <i> et al.</i>: Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS). <i>Rheumatol Int.</i> 2015; <b>35</b>(11): 1943–7. <a target=xrefwindow id=d11054e4219 href="http://www.ncbi.nlm.nih.gov/pubmed/26048626">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4222 href="https://doi.org/10.1007/s00296-015-3305-2">Publisher Full Text </a></span></li><li><a name=ref-121 class=n-a></a><span class=label>121. </span>&nbsp;<span class=citation><a name=d11054e4231 class=n-a></a>Akasbi N, Soyfoo MS: Successful treatment of tumor necrosis factor receptor-associated periodic syndrome (TRAPS) with tocilizumab: A case report. <i>Eur J Rheumatol.</i> 2015; <b>2</b>(1): 35–6. <a target=xrefwindow id=d11054e4239 href="http://www.ncbi.nlm.nih.gov/pubmed/27708919">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4242 href="https://doi.org/10.5152/eurjrheumatol.2014.14053">Publisher Full Text </a> | <a target=xrefwindow id=d11054e4245 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5047242">Free Full Text </a></span></li><li><a name=ref-122 class=n-a></a><span class=label>122. </span>&nbsp;<span class=citation><a name=d11054e4254 class=n-a></a>Vaitla PM, Radford PM, Tighe PJ, <i> et al.</i>: Role of interleukin-6 in a patient with tumor necrosis factor receptor-associated periodic syndrome: Assessment of outcomes following treatment with the anti-interleukin-6 receptor monoclonal antibody tocilizumab. <i>Arthritis Rheum.</i> 2011; <b>63</b>(4): 1151–5. <a target=xrefwindow id=d11054e4265 href="http://www.ncbi.nlm.nih.gov/pubmed/21225679">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4268 href="https://doi.org/10.1002/art.30215">Publisher Full Text </a></span></li><li><a name=ref-123 class=n-a></a><span class=label>123. </span>&nbsp;<span class=citation><a name=d11054e4277 class=n-a></a>Hosoya T, Mizoguchi F, Hasegawa H, <i> et al.</i>: A Case Presenting with the Clinical Characteristics of Tumor Necrosis Factor (TNF) Receptor-associated Periodic Syndrome (TRAPS) without <i>TNFRSF1A</i> Mutations Successfully Treated with Tocilizumab. <i>Intern Med.</i> 2015; <b>54</b>(16): 2069–72. <a target=xrefwindow id=d11054e4291 href="http://www.ncbi.nlm.nih.gov/pubmed/26278305">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4295 href="https://doi.org/10.2169/internalmedicine.54.3371">Publisher Full Text </a></span></li><li><a name=ref-124 class=n-a></a><span class=label>124. </span>&nbsp;<span class=citation><a name=d11054e4304 class=n-a></a>Aksentijevich I, McDermott MF: Lessons from characterization and treatment of the autoinflammatory syndromes. <i>Curr Opin Rheumatol.</i> 2017; <b>29</b>(2): 187–94. <a target=xrefwindow id=d11054e4312 href="http://www.ncbi.nlm.nih.gov/pubmed/27906774">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4315 href="https://doi.org/10.1097/BOR.0000000000000362">Publisher Full Text </a> | <a target=xrefwindow id=d11054e4318 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5823535">Free Full Text </a></span></li><li><a name=ref-125 class=n-a></a><span class=label>125. </span>&nbsp;<span class=citation><a name=d11054e4327 class=n-a></a>Cohen P: Immune diseases caused by mutations in kinases and components of the ubiquitin system. <i>Nat Immunol.</i> 2014; <b>15</b>(6): 521–9. <a target=xrefwindow id=d11054e4335 href="http://www.ncbi.nlm.nih.gov/pubmed/24840983">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4338 href="https://doi.org/10.1038/ni.2892">Publisher Full Text </a> | <a target=xrefwindow id=d11054e4341 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5793992">Free Full Text </a></span></li><li><a name=ref-126 class=n-a></a><span class=label>126. </span>&nbsp;<span class=citation><a name=d11054e4351 class=n-a></a>Zhou Q, Yu X, Demirkaya E, <i> et al.</i>: Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease. <i>Proc Natl Acad Sci U S A.</i> 2016; <b>113</b>(36): 10127–32. <a target=xrefwindow id=d11054e4362 href="http://www.ncbi.nlm.nih.gov/pubmed/27559085">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4365 href="https://doi.org/10.1073/pnas.1612594113">Publisher Full Text </a> | <a target=xrefwindow id=d11054e4369 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5018768">Free Full Text </a></span></li><li><a name=ref-127 class=n-a></a><span class=label>127. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726638542"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e4378 class=n-a></a>Damgaard RB, Walker JA, Marco-Casanova P, <i> et al.</i>: The Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and Autoimmunity. <i>Cell.</i> 2016; <b>166</b>(5): 1215–1230.e20. <a target=xrefwindow id=d11054e4389 href="http://www.ncbi.nlm.nih.gov/pubmed/27523608">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4392 href="https://doi.org/10.1016/j.cell.2016.07.019">Publisher Full Text </a> | <a target=xrefwindow id=d11054e4396 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5002269">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726638542">F1000 Recommendation</a></span></li><li><a name=ref-128 class=n-a></a><span class=label>128. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725996406"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e4409 class=n-a></a>Zhou Q, Wang H, Schwartz DM, <i> et al.</i>: Loss-of-function mutations in <i>TNFAIP3</i> leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. <i>Nat Genet.</i> 2016; <b>48</b>(1): 67–73. <a target=xrefwindow id=d11054e4423 href="http://www.ncbi.nlm.nih.gov/pubmed/26642243">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4427 href="https://doi.org/10.1038/ng.3459">Publisher Full Text </a> | <a target=xrefwindow id=d11054e4430 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4777523">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725996406">F1000 Recommendation</a></span></li><li><a name=ref-129 class=n-a></a><span class=label>129. </span>&nbsp;<span class=citation><a name=d11054e4443 class=n-a></a>Kadowaki T, Ohnishi H, Kawamoto N, <i> et al.</i>: Haploinsufficiency of A20 causes autoinflammatory and autoimmune disorders. <i>J Allergy Clin Immunol.</i> 2018; <b>141</b>(4): 1485–1488.e11. <a target=xrefwindow id=d11054e4454 href="http://www.ncbi.nlm.nih.gov/pubmed/29241730">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4457 href="https://doi.org/10.1016/j.jaci.2017.10.039">Publisher Full Text </a></span></li><li><a name=ref-130 class=n-a></a><span class=label>130. </span>&nbsp;<span class=citation><a name=d11054e4466 class=n-a></a>McInnes IB, Schett G: The pathogenesis of rheumatoid arthritis. <i>N Engl J Med.</i> 2011; <b>365</b>(23): 2205–19. <a target=xrefwindow id=d11054e4474 href="http://www.ncbi.nlm.nih.gov/pubmed/22150039">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4477 href="https://doi.org/10.1056/NEJMra1004965">Publisher Full Text </a></span></li><li><a name=ref-131 class=n-a></a><span class=label>131. </span>&nbsp;<span class=citation><a name=d11054e4486 class=n-a></a>Viatte S, Plant D, Bowes J, <i> et al.</i>: Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients. <i>Ann Rheum Dis.</i> 2012; <b>71</b>(12): 1984–90. <a target=xrefwindow id=d11054e4497 href="http://www.ncbi.nlm.nih.gov/pubmed/22661644">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4500 href="https://doi.org/10.1136/annrheumdis-2011-201225">Publisher Full Text </a> | <a target=xrefwindow id=d11054e4504 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3595982">Free Full Text </a></span></li><li><a name=ref-132 class=n-a></a><span class=label>132. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727756265"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e4514 class=n-a></a>Aki A, Nagasaki M, Malynn BA, <i> et al.</i>: Hypomorphic A20 expression confers susceptibility to psoriasis. <i>PLoS One.</i> 2017; <b>12</b>(6): e0180481. <a target=xrefwindow id=d11054e4525 href="http://www.ncbi.nlm.nih.gov/pubmed/28658319">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4528 href="https://doi.org/10.1371/journal.pone.0180481">Publisher Full Text </a> | <a target=xrefwindow id=d11054e4532 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5489224">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727756265">F1000 Recommendation</a></span></li><li><a name=ref-133 class=n-a></a><span class=label>133. </span>&nbsp;<span class=citation><a name=d11054e4545 class=n-a></a>Adrianto I, Wen F, Templeton A, <i> et al.</i>: Association of a functional variant downstream of <i>TNFAIP3</i> with systemic lupus erythematosus. <i>Nat Genet.</i> 2011; <b>43</b>(3): 253–8. <a target=xrefwindow id=d11054e4559 href="http://www.ncbi.nlm.nih.gov/pubmed/21336280">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4563 href="https://doi.org/10.1038/ng.766">Publisher Full Text </a> | <a target=xrefwindow id=d11054e4566 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3103780">Free Full Text </a></span></li><li><a name=ref-134 class=n-a></a><span class=label>134. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733452222"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e4575 class=n-a></a>Zaidi D, Huynh H, Carroll M, <i> et al.</i>: Tumor necrosis factor α-induced protein 3 (A20) is dysregulated in pediatric Crohn disease. <i>CEG.</i> 2018; <b>11</b>: 217–231. <a target=xrefwindow id=d11054e4586 href="http://www.ncbi.nlm.nih.gov/pubmed/29881302">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4589 href="https://doi.org/10.2147/CEG.S148217">Publisher Full Text </a> | <a target=xrefwindow id=d11054e4593 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5985767">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733452222">F1000 Recommendation</a></span></li><li><a name=ref-135 class=n-a></a><span class=label>135. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733278884"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e4606 class=n-a></a>Zheng C, Huang Y, Ye Z, <i> et al.</i>: Infantile Onset Intractable Inflammatory Bowel Disease Due to Novel Heterozygous Mutations in TNFAIP3 (A20). <i>Inflamm Bowel Dis.</i> 2018; <b>24</b>(12): 2613–2620. <a target=xrefwindow id=d11054e4617 href="http://www.ncbi.nlm.nih.gov/pubmed/29788367">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4620 href="https://doi.org/10.1093/ibd/izy165">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733278884">F1000 Recommendation</a></span></li><li><a name=ref-136 class=n-a></a><span class=label>136. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732442404"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e4633 class=n-a></a>Aeschlimann FA, Batu ED, Canna SW, <i> et al.</i>: A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease. <i>Ann Rheum Dis.</i> 2018; <b>77</b>(5): 728–735. <a target=xrefwindow id=d11054e4644 href="http://www.ncbi.nlm.nih.gov/pubmed/29317407">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4647 href="https://doi.org/10.1136/annrheumdis-2017-212403">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732442404">F1000 Recommendation</a></span></li><li><a name=ref-137 class=n-a></a><span class=label>137. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718501712"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e4660 class=n-a></a>Vande Walle L, van Opdenbosch N, Jacques P, <i> et al.</i>: Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis. <i>Nature.</i> 2014; <b>512</b>(7512): 69–73. <a target=xrefwindow id=d11054e4671 href="http://www.ncbi.nlm.nih.gov/pubmed/25043000">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4674 href="https://doi.org/10.1038/nature13322">Publisher Full Text </a> | <a target=xrefwindow id=d11054e4678 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4126806">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718501712">F1000 Recommendation</a></span></li><li><a name=ref-138 class=n-a></a><span class=label>138. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734083403"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e4692 class=n-a></a>Taraborrelli L, Peltzer N, Montinaro A, <i> et al.</i>: LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L. <i>Nat Commun.</i> 2018; <b>9</b>(1): 3910. <a target=xrefwindow id=d11054e4703 href="http://www.ncbi.nlm.nih.gov/pubmed/30254289">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4706 href="https://doi.org/10.1038/s41467-018-06155-8">Publisher Full Text </a> | <a target=xrefwindow id=d11054e4710 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6156229">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734083403">F1000 Recommendation</a></span></li><li><a name=ref-139 class=n-a></a><span class=label>139. </span>&nbsp;<span class=citation><a name=d11054e4723 class=n-a></a>Boisson B, Laplantine E, Dobbs K, <i> et al.</i>: Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia. <i>J Exp Med.</i> 2015; <b>212</b>(6): 939–51. <a target=xrefwindow id=d11054e4734 href="http://www.ncbi.nlm.nih.gov/pubmed/26008899">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4737 href="https://doi.org/10.1084/jem.20141130">Publisher Full Text </a> | <a target=xrefwindow id=d11054e4741 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4451137">Free Full Text </a></span></li><li><a name=ref-140 class=n-a></a><span class=label>140. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717967626"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e4750 class=n-a></a>Boisson B, Laplantine E, Prando C, <i> et al.</i>: Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency. <i>Nat Immunol.</i> 2012; <b>13</b>(12): 1178–86. <a target=xrefwindow id=d11054e4761 href="http://www.ncbi.nlm.nih.gov/pubmed/23104095">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4764 href="https://doi.org/10.1038/ni.2457">Publisher Full Text </a> | <a target=xrefwindow id=d11054e4768 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3514453">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717967626">F1000 Recommendation</a></span></li><li><a name=ref-141 class=n-a></a><span class=label>141. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732331923"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d11054e4781 class=n-a></a>Krenn M, Salzer E, Simonitsch-Klupp I, <i> et al.</i>: Mutations outside the N-terminal part of <i>RBCK1</i> may cause polyglucosan body myopathy with immunological dysfunction: expanding the genotype-phenotype spectrum. <i>J Neurol.</i> 2018; <b>265</b>(2): 394–401. <a target=xrefwindow id=d11054e4795 href="http://www.ncbi.nlm.nih.gov/pubmed/29260357">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4799 href="https://doi.org/10.1007/s00415-017-8710-x">Publisher Full Text </a> | <a target=xrefwindow id=d11054e4802 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5808061">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732331923">F1000 Recommendation</a></span></li><li><a name=ref-142 class=n-a></a><span class=label>142. </span>&nbsp;<span class=citation><a name=d11054e4815 class=n-a></a>Sennikov SV, Alshevskaya AA, Shkaruba NS, <i> et al.</i>: Expression of TNFα membrane-bound receptors in the peripheral blood mononuclear cells (PMBC) in rheumatoid arthritis patients. <i>Cytokine.</i> 2015; <b>73</b>(2): 288–94. <a target=xrefwindow id=d11054e4826 href="http://www.ncbi.nlm.nih.gov/pubmed/25828588">PubMed Abstract </a> | <a target=xrefwindow id=d11054e4829 href="https://doi.org/10.1016/j.cyto.2015.01.015">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 28 Jan 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/8-111/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/8-111/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Leeds Institute of Rheumatic and Musculoskeletal Medicine (LIRMM), Leeds, UK<br/> <sup>2</sup> Leeds Institute of Medical Research at St. James&rsquo;s, Leeds, UK<br/> <sup>3</sup> Leeds Cystic Fibrosis Trust Strategic Research Centre, Leeds, UK<br/> <p> <div class=margin-bottom> Jonathan Holbrook <br/> <span>Roles: </span> Conceptualization, Project Administration, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Samuel Lara-Reyna <br/> <span>Roles: </span> Conceptualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Heledd Jarosz-Griffiths <br/> <span>Roles: </span> Conceptualization, Project Administration, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Michael F. McDermott <br/> <span>Roles: </span> Conceptualization, Project Administration, Supervision, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/8-111/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 28 Jan 2019, 8:111 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.17023.1">https://doi.org/10.12688/f1000research.17023.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2019 Holbrook J <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=18612 data-id=17023 data-downloads="" data-views="" data-scholar="10.12688/f1000research.17023.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/8-111/v1/pdf?article_uuid=6c81e12c-4ea8-4319-b9f3-695207949622" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.17023.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Holbrook J, Lara-Reyna S, Jarosz-Griffiths H and McDermott MF. Tumour necrosis factor signalling in health and disease [version 1; peer review: 2 approved] <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):111 (<a href="https://doi.org/10.12688/f1000research.17023.1" target=_blank>https://doi.org/10.12688/f1000research.17023.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=17023 id=mobile-track-article-signin-17023 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/17023?target=/articles/8-111/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=18612 /> <input name=articleId type=hidden value=17023 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Rudi Beyaert</strong>, Department of Biomedical Molecular Biology, Ghent University, Belgium </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Lisa Sedger</strong>, Faculty of Science, The University of Technology , Australia </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 28 Jan 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/8-111/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/8-111/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=44903-43377></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=44902-43376></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/8-111/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>28 Jan 19</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Rudi Beyaert</strong>, Department of Biomedical Molecular Biology, Ghent University, Belgium </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Lisa Sedger</strong>, Faculty of Science, The University of Technology , Australia </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/8-111/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/8-111/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Tumour necrosis factor signalling in health...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/8-111/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/8-111/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/8-111/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Holbrook J et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/8-111/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/8-111",
            templates : {
                twitter : "Tumour necrosis factor signalling in health and disease. Holbrook J et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/8-111/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Tumour necrosis factor signalling in health and disease", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Tumour necrosis factor signalling in health and disease", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/17023/18612")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "18612");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "43376": 0,
                           "43377": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "56b67f6a-0b19-458a-90e1-3d1d014bf502";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-111.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-111.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-111.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/8-111.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/8-111.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>